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"THE ART OF CRYOSURGERY"
Cryosurgery is an art as well as a science.
Of course just as a sculptor or painter mus t 
learn about stone, wood, canvas, paper, 
chisels, rasps, paintbrushes, and othe r 
materials, the cryosurgeon must understan d 
the science underlying cryosurgery.
He or she must learn the properties of th e 
various cryogens, the apparatus for applyin g 
them, the three-dimensional extent of th e 
lesion to be treated, and the tissue content o f 
these lesions. He or she should also know th e 
susceptibility of various portions of the targe t 
lesion and surrounding tissues of varyin g 
insults with cold.
Douglas Torre, MD; Cutis 1994; 54: 354.
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CHAPTER 1
GENERAL INTRODUCTION AND AIMS OF THE STUDY
INTRODUCTION
The benefit of the use of cold for medical purposes has been known for a long 
time. The first application was a symptomatic form of treatment for all kinds of 
medical conditions utilizing mainly its anaesthetizing properties.
Later, when the technical knowledge became available to produce very low 
temperatures (less than minus 100oC) its potential power to induce cell death was 
discovered. Destroying diseased tissue like benign and malignant neoplasms 
using extreme low temperatures is now known as cryosurgery and is generally 
accepted as a therapy of value in several medical specialties. Dermatologists 
have been using it for over a century to treat all kind of skin disorders1,2, and 
further on, for example in surgery for the treatment of liver metastases3, prostate 
cancer4 and neurological tumors5.
In 1968 Ralph C. Marcove introduced cryosurgery in orthopaedic oncology for the 
treatment of primary and metastatic bone tumors by repetitive freezing and he 
was awarded the first price in scientific research at the 162nd annual convention 
of the medical society of the state of New York6. Since than only a few 
orthopaedic surgeons dealing with skeletal tumors have adopted the technique 
and the clinical results and experimental data of cryosurgery with specific 
reference to the skeletal system have been published in about 50 papers. Larger 
series of patients, especially "non-Marcove", are with only an occasional 
exception not available, but are required to confirm the benefits of the 
cryosurgical technique.
Cryosurgery is used as adjuvant treatment after intralesional resection 
(curettage) of active and aggressive benign and low-grade malignant, stage IA 
skeletal tumors.7 By spraying liquid nitrogen into the curetted lesion the surgical 
margin of resection is extended. Tumor cells left behind are destroyed by this 
thermal injury, which otherwise could be responsible for a recurrence of the 
tumor. By this method the procedure can be considered to be marginal from the 
point of view of orthopaedic oncologic principles7. The advantage of this kind of 
treatment, as compared with local (en block) resection, is that as much of the 
supportive function of bone is preserved and that reconstructive surgery can be 
limited.
Since the early nineteen seventies, cryosurgery for orthopaedic oncologic 
indications has been used in the University Hospital in Groningen and since 1991 
in the University Hospital in Nijmegen, The Netherlands.
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AIMS
The aims of this thesis are defined as follows:
1 Description of effective cryosurgery by investigation, comprehensive 
recording and distillation of all in the literature available historical, technical 
and biological data of cryosurgery for orthopaedic oncologic purposes.
2 A literature review of all experimental data and clinical results of cryosurgery 
of bone and bone tumors.
3 Investigation of the clinical results, functional outcome and complications of 
cryosurgery as adjuvant therapy for benign and low-grade malignant bone 
tumors.
4 Development and evaluation of equipment for local and general monitoring 
of the cryosurgical process.
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visited for the removal and destruction of brain, spinal and orbital tumours.
Neurol Res 1992; 14: 294-302.
6 M arcove RC and Miller TR and Cahan WC.Treatment of primary and metastatic bone tumors b y 
repetitive freezing. Bull N Y Acad Med 1968, 44: 532-44.
7 Enneking WF. A staging system of staging Musculoskeletal Neoplasms.
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CHAPTER 2
THE MEDICAL USE OF LOW TEMPERATURES
The use of low temperatures has become an essential, sometimes indispensable 
feature in modern western society with many different appliances. Everyone is 
familiar with its use in refrigerators and deep freezers. Air conditioning creates 
not only comfortable surroundings for men, but is also mandatory for the proper 
functioning of not-living things like mainframe computers.
The influence of low temperatures on varying body parts can be confusing; on 
the one hand an acute sports injury has to be treated with a cooling spray, 
preferably "on the spot", on the other hand a sore muscle caused by exposure to 
cold, has to be treated with the application of warmth.
Not only the danger of low temperatures like frostbite, but more its use for the 
treatment of various medical disorders have been known since the time of the 
earliest records. Its beneficial properties were entirely empirical based, like all 
ancient therapies. The use of low temperature, at first derived from snow and ice, 
was based on its anaesthetizing properties and slowing down biological 
processes.1 Later, technical improvements made very low temperatures available 
which had potential killing and destroying abilities on living tissue. Since then, 
low-temperatures have found their use in virtual every specialty of medicine.
HISTORY OF MEDICAL USE OF LOW TEMPERATURES
For reasons of clarity and readability the following historical review is organized 
by chronicity with brief comments and references.
2500BC The writing of the Edwin Smith Surgical Papyrus, later translated by 
Breasted mentioned the use of cold compresses to treat compound skull 
fractures and infected wounds.2 
460BC Hippocrates, the father of medicine, advocated the use of cold to control 
hemorrhage and to reduce swelling of painful joints.3 
1050 An unknown Anglo Saxon monk employed cold as a local anesthetic.4 
1570 Refrigeration anesthesia was known to Italian physicians.5 
1661 Thomas Bartholin of Copenhagen described the use of cold as a 
therapeutic for all kinds of everyday illnesses.6 
1665 Robert Boyle published a monograph on the influence of cold on living 
animals.2
Confronted with the above historical facts, Bradley7 wondered: "and it is 
remarkable that the first physicians to investigate the use of cold within medicine 
are those from warmer climates. Presumably, the difficulties of producing low
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temperatures in prerefrigeration times must have made these treatments as rare 
as modern-day techniques requiring esoteric and unproven drugs or medicines". 
But the above mentioned properties of cold are still used in modern medicine; 
e.g. "coldpacks" for strained ankles and cooling spray as anesthetic to incise 
abscesses.
1714 Fahrenheit invented the mercury thermometer, later reinvented by 
Réaumur (1739) and Celsius (1742).8
The invention of the thermometer is of considerable importance, because it was 
now possible to measure the actual "coldness" or temperature at which all the 
phenomena were happening. Furthermore the efforts to generate lower and lower 
temperatures could now begin. Scientists were now able to standardize their 
experiments and exchange results.
1787 Spallanzani: investigated the effects of temperatures of minus 24oC on 
insects, fish, amphibians, reptiles, birds and mammals. He also 
recognized the existence of water of subzero temperatures without the 
transformation into ice, a physical phase later called supercooling.8 
1832 Dominique J. Larrey, a surgeon in the army of Napoleon, recorded during 
the retreat from Moskou that amputations could be done more or less 
painlessly providing the affected limb had been sufficiently cooled in the 
snow.9 Local refrigeneration has been advocated as the anesthetic of 
choice for limb surgery as recent as 1991.10-15 
1845 James Arnott, an English physician, published his first book on the 
therapeutic use of the local application of cold in a wide variety of 
conditions like headaches, neuralgia and more general diseases.16 Arnott 
used salt solutions containing crushed ice in local applications at about - 
8 to -12oC to various body surfaces to freeze tissues.
1851 James Arnott's second book described the use of cold in the treatment of 
advanced cancers in accessible sites, such as the breast and uterine 
cervix. Treatment was done by irrigation with cold solutions, resulting in 
diminution of the size of the tumor, reduction in drainage and 
amelioration of pain.17
Thus Arnott is most probably the first who used cold for the treatment of 
malignancies.
Although he was not curing them, he considerably reduced the morbidity of 
cancer, especially pain, which sometimes is still a problem. The anaesthetizing 
characteristics of low temperatures were known, but its use to shrink, apparently 
destroying parts of the tumor was now recognized as a new effect of freezing.
1866 Local anaesthesia generated by a spray of ether was first described by 
Richardson and later replaced by ethyl chloride.18
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This method became so popular that the term freezing is still synonymous in the 
English language with local anesthesia. This method of applying cold was a 
technical improvement and made experimental investigations possible. These 
soon followed.
1868 Samuel produced local freezing of the ear of a rabbit by means of an 
ether spray and described the subsequent clinical and microscopic 
changes.19
1883 Openchowski attempted to localize the physiological function of different 
areas within the cerebral cortex of dogs by local freezing. He obtained 
freezing temperatures using the evaporation of ether by a warm jet of 
air. Peripheral convulsions or paralyses produced by this method made 
functional mapping of the cortex possible.20
Until the beginning of the 20th century the "users" of devices producing cold were 
mostly also their "inventors". After the turn of the century these two professions 
became separated. To improve machinery, either for the development of 
cryosurgical instruments or the production of cryogenics a background with more 
engineering schooling was necessary.
1899 Dr Campbell White, an american surgeon stated: "Here and there during 
the past year or two liquid air has been used on several manifestations of 
disease, particularly carcinomata. The results has been glowing accounts 
of its power to abort and cure even malignant disease". He also noted 
that pure cultures of anthrax, diphtheria and typhoid bacilli survived 
immersion in liquid air for more than one hour.21
Furthermore Dr White considers "that we have reason to hope that we 
have in liquid air a therapeutic agent which will remove many otherwise 
obstinate superficial lesions of the body and cure some lesions which 
have hitherto resisted all treatment at our disposal, including the 
knife".22
White later reported again favorably on the possibility of cure of early 
epitheliomas and the palliative benefits in treatment of inoperable skin 
cancer.23 He also quotes a colleague: "No treatment at our disposal 
could have destroyed an epithelioma of this character in so short time 
and with so slight a scar remaining as liquid air has done in this case".
Not all scientists were prepared to accept such confident statements.
The use of low temperatures was in this time in competition with more advanced 
techniques of surgery, especially since general anesthesia was now in 
widespread use. Opposition was often fierce as is shown in the July 1899 edition 
of Scientific American: "The suggested employment of liquid air as a caustic in 
surgical operations is a good example of the absurdities proposed by dishonesty 
or ignorance in order to impress the public".24 
Nevertheless several physicians kept up the pace.
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1907 Whitehouse used liquid air first as a spray. Later, because of the 
difficulties controlling the extent of the freeze lesion, he favored the use 
of cotton swab drained in liquid air, creating the first primitive form of a 
probe.25
1907 Pusey used solid carbonic (CO2) snow and also liquid nitrogen for the 
treatment of benign tumors of the skin.26 
1910 Cold, treating various skin diseases, favored the use of liquid air, but was 
forced to use carbonic snow because of technical difficulties in securing 
air in a liquid phase.27
1929 Irvine and Turnacliff gave a review of the literature on the use of 
cryogenic agents for skin disease up to that time. They emphasized that 
the use of a liquid oxygen spray made the need for applying pressure 
during freezing of skin lesions unnecessary, and thereby pain was 
reduced.28
These four physicians initiated a cryosurgical technique which is still in use. The 
simple treatment of warts by many general practitioners with cotton swabs dipped 
in liquid nitrogen is commonly practiced.
At this time liquid oxygen, which is capable of producing very low temperatures (- 
182,9oC) was used by several physicians. Unfortunately, safety considerations 
related to fire precluded more general use.
1930 In this year the first writing using the term "cryotherapy" to address the 
use of low temperature was published. La Cryotherapy by Lortat-Jacobs 
and Solente described several modalities in which cold or freezing 
temperatures were used in medicine, especially in dermatology and 
gynecology.29
The origin of the term cryotherapy, however, has been attributed to Professor 
Bordos, who used the term "cryocautery" in 1912 in association with his freezing 
apparatus and to Giraudeau who was supposed to have used the term 
"cryotherapy" in 1928.30
The use of low temperatures seems from the beginning of the twentieth century 
until the second world war an exclusive treatment for cutaneous diseases. 
Although there is one exception.
1938 Dr Temple Fay, frustrated by the problem of palliation in patients with 
inoperable cancer revived interest in the therapeutic effects of local 
cooling of tissues other than the skin. He treated a woman with 
intractable pain due to carcinoma of the cervix with massive pelvic 
extension. Refrigeration of the vaginal mass was achieved by inserting a 
hollow capsule connected with a continuous circulation of ice water. After 
48 hours the patient was reported to be pain free and after 5 days 
devascularization and shrinkage of the mass was noted. The 
refrigeration was maintained for 5 weeks after which the patient's
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condition had improved to such an extent that she insisted on leaving the 
hospital.31
1940 After Fay's initial promising experiences he employed cryotherapy on 
124 selected patients with far advanced carcinoma; 19 patients died, 8 
patients with metastases survived more than 5 years, but most important 
95,7% were relieved of pain.32
The outbreak of World War II interrupted the development of cryotherapy. More 
significantly, after the war it became known that the technique of hypothermia 
was employed by German nazis on prisoners in concentration camps without 
anesthesia or preparatory treatment, thereby associating cryotherapy with other 
wartime atrocities. Local cooling was thus limited to external use and was 
principally employed in the treatment of skin diseases. Due to the limiting factor 
of instrumentation, cryotherapy of less accessible sites of the human body 
required further development.
A post world war II renaissance for a broader use of cryotherapy was initiated by 
a paper in the New England Journal of Medicine.
1963 Cooper described a newly developed cryosurgical apparatus using liquid 
nitrogen. "This machine now provides an ideal method of basal-ganglion
surgery for Parkinson's disease.....and other disorders of involuntary
movement has now been carried out....in a consecutive series of 800 
cases". The article describes also the treatment of brain tumors and 
classifies the use of cryosurgery as "a new and significantly helpful 
approach to the problem of deep intracerebral gliomas and certain 
tumors at the base of the brain".
Furthermore: Inoperable cancer of the rectum was frozen with marked 
shrinkage of the tumor and immediate relief of local pain and 
obstruction.33
Most interesting are two editorials in the same journal commenting on "cold as a 
surgical instrument". The first gives a brief historical review of the use of cold 
suggesting that there is nothing "new". Although Cooper's new apparatus is 
acknowledged as "an important step in evolution" but one that "seems to warrant 
further trial and development in other fields of surgery".34 Nevertheless, 
cryosurgery for the removal and destruction of brain, spinal and orbital tumors 
was successfully re-visited in 1992.35
Less friendly is the second editorial entitled Current status of gastric freezing. The 
author is not only discussing the new technique but also warns colleagues to 
employ the new technique without complete knowledge of risk, complications and 
ultimate value. Futhermore he states: "the temptation to use this new method for 
unwarranted financial gain cannot be ignored since there are alleged cases in 
which a fee equal to that for gastrectomy or a similar surgical procedure has 
been charged".36
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The war had not only interrupted things, it also made new techniques available 
and soon science and medicine were booming. The application of low 
temperatures expanded to many scientific fields, each with its own 
developmental history:
Cryobiology: the study of the physical effects of low temperatures on living 
tissue.
Cryogenic Surgery, Cryosurgery: the destruction of tissue in situ through the 
local influence of low temperatures.
Cryotherapy: often used interchangeably with cryosurgery but has broader 
connotations covering all therapeutic uses of low temperatures. Cryosurgery is a 
form of cryotherapy, as is the use of cold packs to prevent tissue swelling. It 
seems further appropriate to use the term cryotherapy when the application of 
low temperature is the only performed treatment, for example: the freezing of 
skin lesion. The term cryosurgery should be reserved for the use of low 
temperatures as it is part of a surgical procedure.
Cryopreservation: The permanent cooling of living tissue to preserve its use at 
a later time. This science made, for instance the extended storage of blood, 
blood derivatives and semen possible. As important as this development was for 
modern medicine it will not further be discussed, because it is beyond the scope 
of this thesis.
Hypothermia: The lowering of the body temperature of the normal homeoterm 
man below 35oC. Lowering the bodies core temperature modifies the internal 
metabolic environment. In combination with anaesthesia it reduces metabolism 
and oxygen needs to such an extent that it permits the interruption of circulation 
safely for longer periods of time. It facilitated cardiac surgery, making direct 
repair of certain lesions possible.37
Cryogenics: The science which is engaged in the development of freezing 
temperatures within a biological system.
THE HISTORY AND DEVELOPMENT OF CRYOGENICS AND  
CRYOSURGICAL INSTRUMENTS
Progress in the attainment of low and very low temperatures is a reflection of the 
technical inventions and advancements throughout history. In looking back the 
apparatuses used in the early days of cryotherapy seem somewhat contrived. On 
the other hand modern cryotherapy instruments, which are perfectly equipped for 
successful treatment today, will probably be deemed inadequate tomorrow. In 
this cryotherapy is comparable to every other advancement in medicine. 
Therefore continuing research to improve current techniques is necessary, in 
particular to answer demands for safety and expanded indications.
Acquiring low temperatures for therapeutic applications in medicine has not been 
difficult for medical specialists. Most of the technology was adapted from other 
industrial developments and breakthroughs.
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1851 Arnott was the first to use some kind of instrument for applying cold. The 
technique was based on cold coming from a freezing mixture of ice and 
salt kept in a metal container. From this a rubber tube was connected 
through which the solution was transported to specially designed rubber 
cushions. These cold cushions were held against the body parts to be 
treated. Temperatures as low as -24oC were achieved.17 
1868 A more practical form of applying low temperatures was the use of ether 
and later ethyl ether as a spray, however these are potentially explosive 
materials.18
The real breakthrough in achieving very low temperatures was the ability to 
liquify and store various gases.
1877 Gailletet, a french engineer, liquefied small quantities of oxygen and 
carbon monoxide by expansion of the gases under high pressure.38 
1883 Wroblewski and Olszewski converted oxygen and nitrogen into a liquid 
state.39
1895 Von Linde applied the Joule-Thompson principle to liquify larger 
quantities of air and extract of liquid nitrogen from it.
Von Linde's liquefaction process begins with compressing water cooled air. This 
cool compressed air is than further cooled countercurrent to outgoing cold 
products, which are normally the waste products of the separation process. The 
cool compressed air is than throttled through an expansion valve. It is here that 
the Joule-Thompson principle becomes effective: the expansion of a gas or 
vapor through a restricted orifice will lower its temperature. At this lower 
temperature, some of the air will liquefy, and can be collected in a container. The 
liquid air can be run through a fractioning column and separated into its various 
components by utilizing their unique boiling points.
1898 The storage of liquid gases extracted from air in a special container was 
made possible by its inventor's name: Dewar.
The Dewar storage container and principle are still in use. The liquid gas is held 
in a container with maximum isolation from its surroundings by virtue of a 
vacuum double wall. In this fashion warmth is withheld from the liquid gas 
preventing evaporation. Storage is possible under normal atmospheric pressures. 
The container is closed by a foam plug. Under these conditions liquid gas will 
only evaporate in small percentages; 1-8% per day, depending on the gas, and 
the size and quality of the container. By replacing the foam plug with an 
adjustable valve, to which a pressure relief and a liquid withdrawal device are 
added, the liquid can be kept under a predetermined pressure, thereby permitting 
convenient withdrawal of liquid from the container. If large amounts of liquid 
need to be extracted in a short time, the pressure can be raised by a heating
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device built into the container. As various liquid gases became available at the 
beginning of the twentieth century, the development of instruments and 
accessories to apply them clinically began.
1907 The earliest instrument was designed by Whitehouse.25 The principles he 
devised are still used in modern hand held liquid nitrogen spray units 
(Figure 1.1).
Figure 1.1: By blocking the short outlet, pressure in the bottle is allowed to build because o f 
vaporization of the liquid, which will force liquid trough the long tube as a spray.
Although the liquefying of different gases was technically possible, it was not
generally available. Until the second World War other means were employed.2
1907 Because Pusey had difficulty in obtaining liquid air he was forced to use 
carbon dioxide snow (-78oC). Carbon dioxide was held in the liquefied 
state by the use of high pressure. When the liquid carbon dioxide was 
released into the air, the decrease in pressure caused freezing and the 
formation of a white snow, which was collected in a leather bag. The 
snow was then compressed into appropriate shapes (sticks) for 
application to the skin.26
1930 Lortat-Jacops and Solente used copper tips of various sizes connected 
to a CO2 source.29
1942 Poppe used frigid air forced under pressure through a copper tube 
packed with CO2.40
1943 Carpenter devised copper probes cooled by solid CO2 pencils.41
1950 Allington introduced the use of liquid nitrogen into medical practice. He 
used cotton swabs dipped in liquid nitrogen.42,43
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The limitations of the liquid nitrogen-soaked cotton applicator and solid CO2 were 
defined by Grimmett who studied frozen tissues microscopically. Liquid nitrogen 
applied in this fashion induced cell death at a maximum depth of 2 mm and CO2 
even less.44
1961 Cooper introduced an automatic cryosurgical apparatus, which used 
liquid nitrogen in a closed system, and which permitted continuous and 
rapid freezing of tissue. Furthermore it featured controls for regulating 
temperature at the tip of the probe.45,46
1966 Zacarian used solid copper cylinder discs, cooled by immersion in liquid 
nitrogen. Their thermal capacity was much better than cotton swabs 
dipped in liquid nitrogen and cell death up to 7 mm from the disc was 
possible.47,48 This was an improvement, but the freezing of large 
quantities of tissues was not possible.
After 1960 a variety of cryosurgical instruments were designed and employed a 
range of cryogens. All designs have special adaptations and auxiliary equipment 
for the specific clinical application. For instance, the probe to perform an 
intracapsular cryoextraction of a lens of the eye is completely different compared 
to the probe used for the treatment of bone tumors.
The increase of general interest in the use of cold temperatures has led to the 
foundation of several organizations.49,50 The most widely known and their 
activities are listed below:
1964 The Society for Cryobiology, publisher of the journal Cryobiology.
1968 The Society of Cryosurgery, publisher of the Journal of Cryosurgery from 
1968 until 1969.
1974 The Japan Society of Low Temperature starts publishing the journal Low 
Temperature Medicine.
1974 The International Society of Cryosurgery organizes meetings with a 3 
year interval.
1977 The American College of Cryosurgery. It has held meetings almost 
annually.
Today about 100 articles concerning the use of low temperatures in experimental 
work or clinical applications in different specialties are published in the English 
literature every year. In the non-english literature, especially Russian, many 
papers are available as abstracts on MEDLINE EXPRESS. This demonstrates 
that interest in every aspect of the use of low temperatures is widespread.
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CHAPTER 3
CRYOPROBE DESIGN, COOLING POWER, 
BASIC TECHNIQUE AND MONITORING
CRYOPROBE DESIGN
The basic design of cryoprobes can be divided into open and closed systems. In 
general, closed systems employ two different principles for creating low 
temperatures at the end of a probe. Since today liquid nitrogen is most 
commonly used, this section will deal specifically with this particular cryogen.
CLOSED SYSTEMS:
A. Boiling at the end of a probe:
The first principle to cool a cryoprobe is allowing liquid nitrogen to boil at the 
end of the tip of the probe; for boiling it extracts latent heat from its 
surroundings, cooling it at the same time. As long as liquid nitrogen is passed 
through the tip fast enough to maintain boiling, the temperature of the tip of 
the probe will remain at the boiling point of liquid nitrogen: -195,8oC (Figure 
3.1). The liquid nitrogen has to be stored in a Dewar container. As the very 
cold liquid nitrogen is transported to the probe, a substantial part of it will boil 
due to all the warm hoses and pipes it passes. Initial performance will 
therefore be compromised and improves only after the entire transport system 
is precooled, which takes some time. The cool exhaust is therefore rerouted 
through the probe. To make sure that only the tip of the probe is freezing, 
extensive isolation of the remaining probe and hose is necessary with in 
addition to the Dewar container makes the system expensive.
B. High Pressure Probes:
The other principle to cool the end of a cryoprobe in closed systems utilizes 
the Joule-Thomson effect. If a pressurized gas is allowed to expand to a 
much lower pressure, its temperature will drop (Figure 3.2). The magnitude of 
change in temperature depends on the change in pressure and the physical 
characteristics of the substance used. The most commonly used gas in this 
kind of probe is nitrous oxide.
The size of the orifice, which facilitates the pressure drop, is crucial for a 
proper operation and performance of the instrument. After expansion the now 
cold gas is transported back along the hose and can cause freezing of the 
probe. To avoid this isolation of the probe is necessary. A further problem is 
that as long the probe is used the pressure in the storage cylinder drops. To 
regain pressure some of the liquid nitrogen has to boil, extracting latent heat 
from the liquid nitrogen left in the storage cylinder, which in its turn cools 
down causing a decrease of pressure.
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High pressure probes are less powerful in cooling, but much less 
expensive compared to liquid nitrogen probes.
Figure 3.1: Closed cryoprobe system, cooling of the tip is achieved by boiling liquid nitrogen in the 
tip of the probe.51
Figure 3.2: Closed cryoprobe system, cooling of the tip is achieved utilizing the Joule-Thomso n 
principle,51 see text.
OPEN SYSTEM:
A. Liquid Nitrogen Sprays:
Spraying liquid nitrogen directly on tissue is an effective, if not the most 
effective way of cooling. The liquid nitrogen cools the tissue by boiling, which 
occurs as heat is extracted from the tissue surface. In this system liquid 
nitrogen has to be transported to the nozzle, therefore this device needs the 
same precooling and thermal isolation as closed liquid nitrogen cryoprobes. 
When the liquid is forced out of the nozzle, the sudden drop of pressure 
causes partial vaporization, a phenomenon called "flashing". Higher original 
driving pressure induces more vaporization, impairing the cooling potency of 
the spray. On the other hand pressures too low will transport only limited 
amounts of liquid nitrogen to the spray nozzle.
Liquid nitrogen drops in the spray will start boiling immediately when coming 
into contact with a higher surface temperature. The initial vaporized gas can 
form a vapor layer between the liquid nitrogen and the target tissue. This 
vapor layer or "film" behaves as an insulator and prevents further cooling of 
the surface. This form of boiling, called filmboiling, can also occur in the 
precooling phase, because the inner surfaces of the hose and probe are still 
relatively warm. Filmboiling causes a pulsatile appearance of the spray. 
Filmboiling will stop only when the complete system is precooled to -175oC.
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Most systems are equipped with a small electrical heater in the tip of the probe 
making defrosting possible facilitating its easy release from the frozen tissue. 
The operational control of cryoprobes in general is carried out by simply stopping 
the flow of cryogen. Stopping the cryosurgery is a decision made by the 
physician. The decision is mainly based on experience. In addition, monitoring 
devices are available, which will be described below.
COOLING POWER
Cooling power of a cryoprobe is defined as the generating of the lowest 
temperature and the time to maintain this temperature.
There are several extrinsic and intrinsic factors which influence the performance 
of a cryoprobe. The intrinsic factors are to a certain extent under the control of 
the physician. The extrinsic factors are related to the tissue being treated.
INTRINSIC FACTORS:
A. Temperature of the tip of the cryoprobe:
As stated above liquid nitrogen probes can produce temperatures as low as 
-196oC and high pressure probes -80oC. Figure 3.3 shows the size of an ice 
ball generated by different tip temperatures after a freeze time of 3 minutes. 
Low tip temperatures also induce a steeper temperature gradient, 
which is more destructive to 
tissue than a slow freeze to the 
same temperature. This 
phenomenon will be discussed in 
detail in chapter 4. Liquid nitrogen 
sprayers produce tissue surface 
temperatures below -175oC.
Figure 3.3: The effect of tip temperature o n 
the ice ball size achieved by a 5 millimete r 
radius probe in 3 minutes.51
B. Duration of freeze:
This is the intrinsic factor which is most easily controlled by the physician. As 
long as the cryoprobe is able to maintain a low temperature, the size of the 
cryogenic lesion will grow, although there is a certain maximum. Figure 3.4 
shows the size of an ice ball plotted in time around a 5 millimeter radius probe 
at a temperature of -150oC. After an initial rapid expansion, there is a more 
gradual increase in iceball size, until a steady state is achieved. At steady 
state the amount of heat being extracted by the probe is balanced by the heat 
supplied by the surrounding tissue.
24 Chapter 3
Io« ball rsdlu» (mm)
° 0  t  ■ »  «  •  • 
■ ryeproiM radlui (mm)
Figure 3.4 (left): The effect of cryoprobe radius on the size of ice ball achieved in 5 minutes for a 
tip at -196oC.51 Figure 3.5 (right): The growth of an ice ball around a 5 millimeter radius probe at - 
150oC.51
C. Contact area between probe and tissue:
Increasing the contact area between probe and tissue enlarges the size of the 
iceball formed around the probe (Figure 3.5).
The effective area of contact of a liquid nitrogen sprayer is as large as the wetting 
area of the sprayer showing obvious freezing. Filmboiling, as explained above, 
will also occur when liquid nitrogen is sprayed on warm tissue. Liquid nitrogen 
droplets, supported by the vapor layer will than tend to flow across the surface 
and may extend to tissue out of the target area, causing unwanted freeze lesions. 
As soon as tissue temperature drops below -175oC, filmboiling will stop.
EXTRINSIC VARIABLES:
A. Tissue thermal conductivity: All biologic tissues have unique thermal 
conductivity properties. The thermal conductivity of any tissue is defined as 
the Joules of energy needed to induce a temperature difference of one degree 
Celsius over a distance of one centimeter in one second.
B. Tissue density: Tissue density, which is the amount of tissue (grams) per 
volume (cubic millimeter). It has a direct influence on thermal conductivity.
C. Tissue specific heat capacity: This capacity of tissue is defined as the amount 
of energy (Joules) obtainable from one gram of tissue per degree (Celsius).
D. Tissue metabolic heat: This is defined as the energy which one cubic 
millimeter of tissue is able to produce in one second by elevating its metabolic 
rate. Elevation of metabolic activity as reaction to cooling is a normal cellular 
"first aid" response.
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E. Blood perfusion: The perfusion of blood is regulated by the organism 
involved. When bloodflow to the area frozen is high the effect can be 
considerable, because of the extra heat source it provides. In some practical 
situations, when a lesion is located on an extremity the physician can block 
this extra heat source by applying a tourniquet to the extremity, thereby 
inducing local circulatory arrest.
BASIC TECHNIQUE
The basic medical principle that any therapy should be maximally effective with a 
minimum of morbidity also applies to cryosurgery. An optimally performed 
cryosurgical treatment should only produce a predictable and predetermined area 
of tissue necrosis. Because the development of cryosurgical instruments has 
been guided by this principle, today a suitable instrument is available for almost 
every cryotherapeutic application. Current emphasis is thus directed to 
maximizing effectiveness with monitoring and avoiding local and/or general 
morbidity.
The basic technique of cryosurgery concerns two different issues:
A. An effective use or exploitation of biological mechanisms leading to cell death 
under the influence of low temperature. It has been shown that the most 
effective way to achieve this is rapid freezing and slow thawing, done in 
repetitive cycles.
B. To establish the suitable cryobiological circumstances mentioned under A, the 
freezing of tissue requires an efficient technique in situ to extract heat from 
the tissue.
The requirements for rapid freezing are:
A. A cryogen suitable for the lesion, not only providing potential cooling power 
but also in sufficient quantities. Furthermore it must be safe (nontoxic and 
nonflammable), easy to store and transportable, and preferably inexpensive. 
For orthopedic purposes only liquid nitrogen meets all these criteria, either 
used in closed probe systems or as a spray.
B. The contact area between the lesion and the cryogenic device should be as 
large as possible facilitating rapid transport of heat. The surface of a lesion in 
orthopedic oncology is always irregular and frequently large. These surface 
properties nearly always necessitate the use of a liquid nitrogen spray instead 
of a probe (Figure 3.6).
The most lethal factor for cells is the maximum reached subzero temperature. 
The basic question to hold the tissue for a certain period in the frozen state at a 
lethal temperature before thawing is not yet answered. Commonly prompt 
thawing is allowed when a preselected temperature has been reached.
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Figure 3.6: A cryoprobe (left) is not able to freeze an irregular surface like spongiosa, a spray wi l 
wet the complete lesion (right).
The principle for slow thawing requires only patience on behalf of the surgeon. 
Ideally frozen tissue should be allowed to completely thaw without assistance. 
While rapid freezing can be achieved in less than 30 seconds, spontaneous 
thawing in the orthopedic setting can take up to ten minutes or more. The 
thawing rate is most influenced by nearby heat sources such as blood vessels. In 
order to achieve a slow thaw rate, the use of a tourniquet to induce circulatory 
arrest, when possible, is appropriate.
The necessity for repetitive freeze and thaw cycles is explained in chapter 4. 
Performing them is a technical matter affected principally by the capacity of the 
chosen equipment. The optimal interval between cycles has received little 
attention in the literature. In general additional cycles are begun after the frozen 
target tissue has warmed to above 10oC.
When a lesion is selected for cryosurgical treatment care should be taken to 
ensure that an adequate margin of normal tissue is included in the freeze injury. 
When a lesion is too large for a single freeze, it may be frozen in sections, with 
each section overlapping the other.
The operative technique of cryosurgery in orthopedics is described in methods 
and patients, chapter 10, page 87.
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MONITORING
A cryosurgical procedure with a satisfactory result can be achieved by using only 
the physician's clinical judgement and experience. Typically in freezing soft 
tissue lesions, the progress of the treatment can be followed by observation and 
palpation. The depth of freezing is most difficult to access clinically and can be 
estimated by observing the lateral spread of freezing in the target tissue.52 
Although clinical judgement of freezing extent is reasonably accurate, it is 
probably not enough to perform "state of the art" cryosurgical procedures. There 
are several reasons to use more precise monitoring devices:
A. To ensure that lethal temperatures are reached. The temperature of frozen 
tissue cannot be determined by its appearance as frosted tissue looks the 
same at any freezing temperature.
B. An accurate measurement of the depth of the freezing is important not only 
for obtaining adequate margins, especially if the lesion has a malignant 
nature, but also to avoid an unwarranted extension of the freezing and 
potential morbidity.
C. Local temperature measurement enables a more precise determination of the 
ending of the thawing phase.
D. Not only is local monitoring important, but systemic monitoring is also 
recommended, since cryosurgery has been associated with potentially lethal 
circulatory and pulmonary complications.
E. Monitoring and preferably recording of the cryosurgical procedure enables the 
physician to evaluate the procedure itself, for instance the freezing rate and 
better interpret follow-up results with respect to the procedure. Adjustments in 
technique can be developed and introduced. Scientific research on data will 
ultimately improve the quality of cryosurgery.
F. When the whole freezing procedure is recorded it provides written evidence 
which can be of medicolegal importance.
MONITORING DEVICES:
To supplement clinical judgment during cryosurgery a range of monitoring 
devises and techniques has been developed. Many of these have been 
developed to address monitoring needs specific to individual applications of 
cryosurgery.
A. Thermocouples:
Thermocouples are formed by a series of two dissimilar conductors, for 
instance iron and constantan, in a closed circuit. When the junction of the two 
metals is subjected to a different temperature from the rest of the circuit, an
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electromotive force proportional to the difference in temperature is generated. 
This voltage can be measured. The thermocouple is commonly mounted in 
the tip of a hollow needle to facilitate its use. Thermocouples were first used 
to monitor cryosurgery of skin lesions. Their importance was recognized early 
in cryosurgical practice, particularly in establishing lethal temperatures.53 The 
accuracy of the thermocouple readings is important as the effectiveness of 
treatment partially depends on it. Proper calibration and reliable hardware 
(good quality of thermocouple, wiring, electrical connections and display 
devices) are imperative. Even more critical is the correct placement of the 
thermocouple itself: a one millimeter variation in the thermocouple positioning 
can represent a 10-15oC temperature difference,54 and checking their position 
with radiographs is sometimes necessary (see chapter 11). Also if the needle 
shaft passes through a frozen area, conductance of heat may result in falsely 
low readings.
Extraneous heat sources in contact with any part between the tip of the
Figure 3.7: Thermocouple 1 is situated intralesional; 2 extracortical, adjacent to the lesion; 3 
between the lesion and the vascular bundle and 4 close to the vascular bundle.
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thermocouple and the recorder can also alter the reading.55,56 Preferably 
several thermocouples are in situ at different locations.
Measuring temperature with thermocouples is helpful in performing the 
following important functions (Figure 3.7):
* to establish lethal temperatures in the frozen lesion itself.
* to achieve sufficient margins at the edge of the lesion.
* to avoid freeze injury of structures nearby (neuro-vascular bundle).
* it gives information about freeze and thawing rates.
B. Tissue impedance and resistance measurements:
Normally unfrozen tissue is a conductor of electricity. During freezing 
electrical conductivity decreases due to the removal of water as a result of the 
formation of ice. When all extracellular water is frozen, electrical resistance 
rises rather abruptly to high levels. This change is known as "eutectic 
freezing" and is interpreted as being indicative of freezing sufficient to induce 
cell death. This technique of monitoring can only be used in soft tissues. In 
the past a wide range of tissue temperature values have been observed in 
relation to electrical impedance changes causing concern about the reliability 
of this monitoring technique.57-60
C. Thermography:
Special cameras capable of measuring infrared radiation from the body 
surface can be used to define isotherms down to -100oC, visualized in a 
thermogram. During freezing thermography can ensure that the whole lesion 
is within the appropriate lethal isotherm.61,62
D. Ultrasound:
When water is frozen its density decreases about 10%. This increases the 
transmission of sounds and distinguishing it from unfrozen areas is possible. 
The technique is only employable on surfaces where direct contact between 
the ultrasound probe and tissue is possible such as the skin and liver.63,64 That 
stipulation prevents its use in orthopedic oncology.
E. Computerized Tomography:
The principle of this monitoring technique is based on the phase change of 
water during freezing and the resulting alteration in its density. It currently is 
used in cryosurgery of the brain.65 The logistics and cost of intraoperative CT 
monitoring sharply limits its use in orthopaedic oncology.
F. Magnetic Resonance Imaging:
After the development of MRI compatible cryosurgical instruments,66 data 
were published describing the use of MR as monitoring device during 
cryosurgery in order to visualize the extent of the freeze not only in relation to 
the temperature achieved,67 but also to the histological outcome.68 Specific 
post-cryosurgical MR appearances of bone tumors were described.69
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CHAPTER 4 
CRYOBIOLOGY AND IT'S EXPLOITATION TO INDUCE 
CELL DEATH
To understand the effects of cooling, freezing and thawing on the biology of living 
cells, it is mandatory to review the physical changes occurring during freezing to 
the main component of tissue; water.
The state or phase (vapor, liquid or solid) of water depends on temperature, 
pressure and volume. The liquid and solid phase of pure water are in equilibrium 
at atmospheric pressure and 0oC. By increasing pressure this temperature (0oC) 
or freezing point can be lowered. This phenomenon of pure water with a subzero 
temperature is known as supercooling.
When its temperature is lowered, pure water will shift to a solid state by either 
vitrification or crystallization. Very rapid cooling of pure water will induce 
vitrification which entails the formation of amorphous, transparent, glasslike 
structures rather than crystals.70 Crystallization requires initiating nuclei, for 
instance an insoluble crystalline impurity.71 Slow cooling rates of water (< 
1oC/min) will induce large crystals around a few nuclei. During fast cooling rates 
many small crystals are formed which are thermodynamically unstable and tend 
to join each other by recrystallization to minimize their surface energies.72 
During freezing of solutions, ice crystals remove more and more pure water from 
the solution, elevating the dissolved solute concentration and lowering the vapor 
pressure of water to that of ice at the same temperature. In this situation solid 
and liquid phase coexist and is, as mentioned earlier called supercooling. The 
supercooled phase ends with a sudden rise of the temperature due to dissipation 
of latent heat generated by the recrystallization of the thermodynamically 
unstable small crystals. The temperature at which both solute and solvent will 
become solidified is called the eutectic temperature (Figure 4.1).
A
changes in a system which i s 
continously further cooled in time; se e 
text for explanation. tim e
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FREEZING OF TISSUE
The freezing of tissue is more complicated since its solvent (water) is divided by 
cell membranes into extracellular and intracellular compartments. Cell 
membranes in general easily allow the passage of water, but far less readily 
allow passage of other solutes.
When tissue is subjected to a constant slow lowering of temperature it first enters 
a supercooled phase without ice formation. Temperatures of 10-15oC below zero 
will initiate ice formation in the extracellular compartment. The intracellular 
compartment remains unfrozen because it's milieu contains substances with high 
and low molecular weight, which lower freezing temperatures. Due to the freezing 
of water in the extracellular compartment concentration of solutes will rise, 
creating an osmotic pressure induced transport of water from the intra- to the 
extracellular compartment. This loss of water will lead to shrinkage of the cell, 
accompanied by higher concentrations of the solutes, which further prevent the 
formation of ice in the intracellular compartment.73 This shrinkage and high 
concentration of solutes, especially of salts, may be responsible for cell injury 
during slow cooling.74
Very rapid cooling induces intracellular ice formation,75 because there is 
insufficient time for water leaving the cell to maintain osmotic equilibrium across 
the cell membrane. Intracellular ice formation is believed to be lethal to the cell. 
Based on histological investigations it has been shown that intracellular ice 
causes mechanical damage to the membrane,76 and disturbs the function of 
mitochondria77 and other cell organelles and membranes.78-81 
The injury to cells occurring during rapid cooling is called thermal shock.
THAWING OF TISSUE
During thawing the "behaviour" of the ice crystals is dependent on the rate of 
thawing. In contrast to rapid thawing, slow thawing is accompanied by 
recrystallization and the crystals can grow to damaging sizes.82 The damaging 
effect of intracellular ice crystals, only formed during rapid freezing can therefore 
be exploited a second time, if slow thawing is allowed, thereby enhancing 
recrystallization. On the other hand, if tissues have been cooled slowly, causing 
shrinkage and intracellular dehydration, rapid thawing may be damaging because 
the cells are exposed to high electrolyte concentrations.83
MICROCIRCULATORY FAILURE IN FROZEN AND THAWED 
TISSUE
After thawing there is typically a brief period of vasodilation. Additionally the 
endothelium of blood vessels is particularly sensitive to freeze-thawing, leading 
to increased permeability of vascular walls, interstitial edema, slowing of
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circulation and platelet aggregation. Capillary obstruction and vascular stasis 
ensues resulting in tissue ischemia and cell death.84,85 The importance of 
postthaw ischemia was demonstrated in an experiment in which carcinoma cells 
transplanted directly after being subjected to cryosurgery would grow in the host, 
but did not survive if transferred 48 hours after the cryosurgery. Histological 
examination of these tumors revealed widespread vascular thrombosis.86 In 
bone, microangiography has demonstrated a total avascularity of the cortex to 
cryosurgery.87
The loss of blood supply in cryosurgically treated tissues deprives all cells of any 
possibility of survival. Ischemia results in uniform necrosis of tissue, except at 
the periphery of the lesion.
THE VALUE OF REPETITIVE FREEZE THAW CYCLES
It is necessary to repeat the freeze and thaw cycles several times because living 
tissue is capable of resisting thermal injury and it is technically difficult to achieve 
optimal conditions for cell death in all areas of many lesions. To compensate, 
repetition of freeze thaw cycles is a practical solution and creates safety 
especially at the periphery of the lesion. After the first cycle, thermal conductivity 
in the tissue is increased, and the specific heat capacity and vascularity are 
decreased. This pre-conditions the tissue, making the next cycles more effective 
by virtue of faster cooling and slower thawing rates. The benefit of repeat cycles 
is well established in the literature.88-91
HOW LOW IS THE LETHAL TEMPERATURE?
The answer to this question depends upon where the temperature is measured: 
close to center of the lesion and the cooling source, or at the periphery where 
temperatures may be higher. With this thought in mind the exact temperature 
which is supposed to be lethal for cells has been lowered during the last 50 years. 
Whereas a temperature between -10 to -20oC was thought to be sufficient in 
1949,92 it was soon turned into less than -20oC.53,93 Authors of later experiments 
on animals advocated temperatures between -20 to -30oC.94 In some 
experiments in vitro total cell death was achieved only with temperatures of -40 
to -50oC.85 In treating cancer cells the minimum in vivo temperature advised is - 
50°C.90,96'98 In 1979 -30oC was thought to produce a marginally lethal injury. 
Therefore a safer technique was proposed especially for neoplastic tissue. It 
required -40oC in normal tissue surrounding the lesion.99 More recent the -60oC 
isotherm beyond the periphery of the lesion is accepted as adequate treatment.100
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In summary, cryosurgery is most effective in inducing tissue necrosis when the 
following features are employed:
- rapid cooling to induce intracellular ice formation
- temperatures as low as -50oC
- slow spontaneous thawing creating intracellular recrystallization
- repetitive freeze thaw cycles using the "conditioned" tissue properties of 
previous cycles.
There is also some evidence101 that this program should be further modified by 
maintaining the tissue in the frozen state for several minutes as is shown in 
Table 4.1
PROGRAM
TEMPERATURE
-15 to -24oC -25 to -35oC -36 to -50oC
I fast/fast 23.5 21.7 66.7
II fast/slow 55.5 62.5 87.5
III fast/hold/fast 50.0 65.3 100.0
IV fast/hold/slow 72.7 93.1 100.0
V slow/fast 0 31.5 50.0
VI slow/slow 28.6 64.7 100.0
Table 4.1: The tissue kill rate (%) in several programs of freezing and thawing with or without holding.
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CHAPTER 5
A LITERATURE REVIEW OF CRYOSURGERY WITH 
SPECIFIC REFERENCE TO THE SKELETAL SYSTEM
A careful review of the literature reveals that cryosurgery is not as generally 
accepted in the treatment of diseases of the musculoskeletal system as it is in 
other categories of disease such as dermatologic disorders.43 It has been adopted 
only by a handful orthopedic surgeons. However, its use for bony pathology of 
the maxilla, mandible and facial bones is more commonly accepted and has 
resulted in a substantial body of basic research.
It seems that cryosurgery for orthopedic pathology is more generally practiced in 
Russia, considering the many (very) brief English abstracts appearing in Medline 
Express. Unfortunately the original articles are published in Russian Journals, 
and are not easy available.
EXPERIMENTAL DATA ON CRYOSURGERY OF BONE
Extensive research has been done to establish the histological changes of bone 
after it has been subjected to low temperatures.
Gage and Emmings (1967) produced freezing injuries in canine femurs and 
mandibles in situ by coiling a latex rubber tubing around the bone through which 
liquid nitrogen was allowed to flow at a high rate. The animals were subsequently 
sacrificed at various intervals and the bones removed. Histological examination 
demonstrated that the full extent of the freezing injury was only evident after 
several days. Osteocytes were slow to disappear, but within seven days the 
frozen bone contained no living cells. However, after a few days, repair was seen 
in the form of osteogenesis initiated by vital bone and periosteum at the border of 
the devitalized segment. Dead bone was slowly replaced by vital bone and after 
one month a thin layer of trabecular subperiosteal new bone covered the nonvital 
shaft. In time this layer thickened and at approximately four months a strong 
sleeve of compact bone enclosed the devitalized segment. The reparative 
changes of the medullary cavity began earlier, but ended later when compared to 
the subperiosteal repair. Between one and two months revascularization was 
apparent and the bone was weakened by resorption. Fractures of the femurs 
were common during this time. Long term observation indicated that the whole 
process of resorption and revitalization ending in complete repair took about one 
year.102
These histological sequences were acknowledged by Hausamen (1973) who 
froze the mandibles of rabbits and by Schargus et al (1975) who froze rabbit 
tibias.103,104 The sequence of radiographic features observed during these 
experiments began within two weeks. Initially repair was seen as periosteal
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thickening at the border of the frozen segment, which grew larger and finally 
covered the whole lesion. The radiologic structure of the frozen bone did not 
change during the first four weeks. Afterwards slow resorption of the dead bone 
was seen as delicate subperiosteal translucent areas appearing in the frozen 
segment, until the whole frozen segment was replaced by new bone. This 
process of radiographic remodelling in rabbits took about 12 weeks. It has been 
shown equal in dogs, but in this species it took more time, up to 6 months.105 
Marcove (1971) suggested that bone responds to freezing in a special manner 
whereby the cellular elements are destroyed but not the calcified matrix so that, 
unlike soft tissue, the structural integrity of bone is maintained.106 
Kuylenstierna et al (1980) investigated the early vascular changes after 
cryosurgery in the rabbit mandible with microangiography. After 30 minutes a 
total avascularity of the cortical bone corresponding with the cryosurgically 
exposed area was seen. After 48 hours, however, the avascular area far 
exceeded the cryosurgically exposed area and extended into the soft tissue 
surrounding the bone.107 These results further supported the hypothesis that 
postcryosurgical ischemia is a major cause of cell death. Two weeks after 
cryosurgery the marrow cavity became filled with dilated and tortuous vessels, 
which initiated a recanalization of the old haversian canals and retained their 
normal size and number after 12 weeks. Cortical vascularity returned to normal 
after 24 weeks.87
Kuylenstierna et al (1981) proved in further experiments using fluorochrome 
labeling that early (four weeks) revitalization of the medullary cavity occurred in 
concurrence with his angiographic results, thus demonstrating the importance of 
intramedullary (endosteal) osteogenesis.108
Bradley et al (1975) defined three post-cryosurgical phases: necrotic, osteogenic 
and remodelling. Furthermore, he suggested that cryosurgery of some 
neoplasms could obviate radical resection of bone and the need for 
reconstruction. To test the efficiency of cryosurgical treatment he compared 
several different cryosurgical techniques and monitored the results with 
thermography. He concluded that the use of a liquid nitrogen spray was most 
effective, allowing rapid freezing of large volumes of bone despite irregular 
surfaces.62 In this respect he also demonstrated the shortcoming of a cryoprobe. 
Kerschbaumer et al (1980 and 1984) advocated a cryosurgical technique for 
bone in which an intramedullary cryoprobe was introduced adjacent to the lesion 
through a cortical window. This method has some disadvantages. First, direct 
visualization of the lesion is not possible. Also, a cortical window placed next to 
the lesion treated with cryosurgery further weakens the bone and frequently 
makes osteosyntheses necessary.109,110
In an effort to find an alternative for high condylectomy in the management of 
painful degenerative arthritis of the temporomandibular joint, Marciani et al 
(1986) performed a cryosurgical lesion of the mandibular condyle in monkeys. 
The structure of bone remained intact and revitalized over time but the articular 
cartilage was irreversibly damaged.111
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Lenz and Preussler (1975) and Schneider (1981) proved respectively in immature 
rabbits and dogs that the epiphysis of long bones subjected to cryosurgery will 
result in its arrest and or growth disturbances causing severe deformity of the
limb.112,113
One of the most interesting experiments involving the therapeutic effect of 
cryosurgery on murine osteosarcoma was conducted by Müller et al (1985). 
Artificially induced osteogenic sarcomas in the hindleg of mice were treated with 
either cryosurgery, local resection or amputation. Cryosurgically treated mice had 
significantly fewer metastases compared to amputation, which was felt to be 
related to a cryosurgically induced immunological protection, although 
measurement of immune parameters could not sustain this claim. Local resection 
yielded the poorest results with 100% local recurrence and the greatest number 
of metastases. Transplanted tumor material treated with one cycle of cryosurgery 
produced new tumors in 80% of the hosts, while tumor material treated with two 
cycles of cryosurgery could not produce any tumors after transplantation.114 
The effect of cryosurgery on the strength of bone was tested by Fisher et al 
(1978). The mandibles of rats had a reduction in strength of approximately 30% 
eight weeks after cryosurgery. The gradual loss of strength in these bones 
paralleled observed radiographic osteolysis. At four months the mandibles had 
regained strength accompanied by clear radiographic evidence of sclerosis.115 
Although not investigated in this experiment, the gradual loss and return of 
strength in cryosurgically treated bone also parallels histologic evidence of bone 
resorption, repair and remodelling.102-104
McCord and Bradley (1989) investigated the effect of two ceramic materials, 
dense hydroxyapatite and beta tricalcium phosphate, implanted over 
cryosurgically treated mandibles of rats at a subperiosteal level. Not only were 
the results of Fisher et al 1977 confirmed, but both of these materials were found 
to prevent the loss of strength due to cryosurgery.116
Malawer et al (1988) demonstrated in an experiment using dogs, that cryosurgery 
can produce bone necrosis 7 to 12 millimeter away from the surface of the cavity 
being treated, in contrast to the minimal zone of necrosis produced by the heat of 
polymerization of polymethyl-methacrylate. In contrast to earlier studies,111'113 he 
found that cryosurgery had no effect on articular cartilage.117 
Yun et al (1993) compared the effect of cryosurgery, phenol cautery and packing 
with bone cement in terms of bone necrosis and subsequent healing of surgical 
defects in the dog femur. The authors demonstrated that cryosurgery produced 
necrosis between 2.5 and 14 mm away from the lesion. The heating effect of 
bone cement produced necrosis at a depth of 1.3 to 2.8 mm. Phenol produced 
negligible necrosis away from the surface of the bone being treated. Complete 
regeneration in the region of necrosis after cryosurgery was observed by 24 
weeks. The authors concluded that cryosurgery could play a significant role as a 
surgical adjunct to curettage in locally aggressive benign tumors and in some 
malignancies. Packing with cement was felt to be useful only in benign cases. 
Phenol cautery was not regarded as an adequate treatment after curettage of 
bone tumors.118
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Oeseburg (1977) published a thesis called "Cryosurgical treatment of some 
bonetumors, an experimental and clinical investigation". He performed a 
cryosurgical "en block" lesion in the forleg of 55 rabbits, which was investigated 
at fixed intervals after the freeze. Radiographical and histological examination 
showed a partial repair after 4 weeks and a complete repair of the "en block" 
frozen tissues after 8 weeks, with the exception of cartilage.119 
De Vries (1983) conducted experiments in rats and rabbits to evaluate the 
problem of bonemarrow embolism during cryosurgery. It was concluded that the 
intravasation of bone marrow was caused by increased intramedullary pressures 
and embolization of bone marrow was encountered, but not on a large scale. 
Most of the bonemarrow intravasations remained locally in the extraosseous 
veins120.
CLINICAL DATA ON CRYOSURGERY OF BONE
The first cryosurgical treatment for musculoskeletal disease was performed in the 
early nineteen sixties. Marcove et al (1968 and 1969) in New York, USA 
introduced the technique in 1964 for the treatment of pain caused by bony 
metastases that had failed to respond to radiation therapy. Encouraging initial 
clinical results, laboratory research and technical improvements resulted in 
expansion of the indication for cryosurgery to primary benign bone tumors such 
as aneurysmal bone cysts and giant cell tumors as well as low-grade malignant 
bone tumors such as chondrosarcoma. Local recurrence rates with this treatment 
were found to be low and early morbidity declined with experience.121-123 These 
three papers of Marcove, although in different journals, but with the same 
message and material were the first of a long series concerning the use of 
cryosurgery in musculoskeletal oncology by this author.
Gage et al (1968), New York, USA, was less enthusiastic about his early 
experience with the cryosurgical treatment of bone: "In general we have been 
disappointed with the results obtained in the treatment of bone tumors. Early 
impressions of benefit from favorable response after freezing have been altered 
by sobering evidence of persistent tumor". But Gage had confidence in the future 
based on his favorable experience with soft tissue tumors: "It is likely that better 
results will follow improvements in technique".124
After first publishing the results of 25 patients with giant cell tumor,125 Marcove et 
al (1978) added a second series of 27 patients all treated with cryosurgery. The 
improvement in technique was the direct pouring of liquid nitrogen into the 
curetted cavity, which gave a reliable filling and freezing of the irregular walled 
cavity. To detect local recurrences almost all cases were subjected to "second 
look biopsy". Although clinically inapparent and not detectable on radiographs, 
microscopic examination of these biopsies revealed 9 patients with residual 
tumor among the first 25 patients. In the second series 3 patients had viable 
tumor. Complications of cryosurgery, particularly fractures, decreased sharply to
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acceptable levels in the second series of patients. All neuropraxias following 
cryosurgery resolved almost completely.126
Marcove et al (1977) reported on the treatment of 18 patients with grade 1 and 2 
chondrosarcoma with curettage and cryosurgery. Soft tissue masses were frozen 
as well. 12 Patients required further operative treatment for microscopic 
recurrence as shown by second look biopsy (6 patients) and/or postcryosurgical 
fractures (6 patients). Transient nerve palsies were seen in 4 patients. Seven 
patients ultimately required en bloc resection or ablative surgery necessitating 
massive reconstructive procedures, and compromising the initial goal of 
cryosurgery, which was to avoid the loss of bone stock. However, after 66 
months of follow-up all but one of the patients was free of disease.127 
Marcove et al (1977) used cryosurgery in combination with internal fixation for 
the treatment of pathological fractures due to metastases from renal cell 
carcinoma. He reported good local control and disease palliation.128 
Marcove's initial successes with cryosurgery for bone tumors resulted in more 
widespread usage of the technique.
Oeseburg et al (1978) from the Netherlands reported five cases of aneurysmal 
bone cyst treated with curettage and cryosurgery to extend the surgical margin 
without further loss of bone. Bone grafts were used to fill the cavity. After a mean 
follow-up of 35 months no recurrences were seen.129
Popescu and Spirescu (1980) from Romania treated four mandibular tumors with 
mandibular hemiresection, extracorporal cryosurgery and immediate 
reimplantation, a technique based on the experimental work.130,131 One case had 
almost 100% and another partial incorporation of the treated bone. Two failed 
treatment because of infection.132
Mirra et al (1981), Los Angeles, USA, reported on the successful treatment of a 
low-grade neoplastic giant-cell tumor of the C2 vertebral body with a combination 
of cryosurgery and radiotherapy. The entire body of C2 was deeply frozen. The 
spinal fluid proved to be an effective barrier in preventing freeze injuries of the 
spinal cord. Fifty-three months after operation there was no evidence of 
recurrence and the vertebral body was completely remodelled.133 
In a review article Marcove (1982) described his long term experience with 
cryosurgery for malignant lesions, which had been published separately.123,127,128 
He also provided further results of this treatment for benign bonetumors. He 
added 50 patients with giant cell tumor to his previous 52 patients125,126 and found 
a local recurrence rate of only 2%. Twenty-three patients with unicameral bone 
cysts and 33 patients with aneurysmal bone cysts each had two local 
recurrences. In 18 patients with chondroblastoma there were three local 
recurrences. Four patients with fibromyxoma of bone, seven with fibrous 
dysplasia and four with eosinophilic granuloma all had no local recurrences.134 
The primary cryosurgical treatment of three patients with osteosarcoma was first 
performed by Marcove et al (1984). Second-look biopsy revealed no residual 
tumor. One patient needed an above knee amputation because of infection and a 
second underwent multiple wedge resections of lung metastases. The three 
patients were free of disease at six, nine and 38 months after initial treatment.135
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Gartsman and Ranawat (1984), New York, USA, reported the successful use of 
cryosurgery as adjuvant treatment after curettage of a recurrent osteoid osteoma 
of the proximal phalanx.136
Russe et al (1984) from Germany treated 27 benign bone tumors of various type 
with curettage and cryosurgery. He had four local recurrences. He also reported 
that in 15 patients with malignant metastatic disease, good local control was 
achieved.137
Jacops et al (1985), Milwaukee, USA updated their results of cryosurgery for 
giant cell tumor published in 1983.138 Two out of 12 patients had a local 
recurrence and required further treatment. Five patients suffered six 
postcryosurgical fractures. After an average follow-up of 51 months all patients 
were free of disease.139
de Vries et al (1986), The Netherlands, treated four chordomas in situ by freezing 
the tumor. In two patients it was technically possible to freeze the entire tumor 
through a dorsal approach. They were alive 12 and 7 years after the operation, 
but one needed self catheterization. One patient died with recurrent disease at 
five years. One patient was alive with recurrent disease at four years.140 
Meals et al (1989) Los Angeles, USA successfully treated a giant cell tumor of 
the metacarpal bone with curettage, cryotherapy and bone grafting. Mild 
paresthesia complicated the treatment but resolved within six months.141 
Malawer and Dunham (1991) Washington, USA reviewed 25 pediatric patients 
with aggressive benign tumors all treated with cryosurgery. The average follow- 
up period was 60.8 months. The local recurrence rate was 4% and secondary 
fracture rate 8%. The functional outcome was fair in one patient (4%), good in 
13% and excellent in 83%.142
Pogrel (1993) San Francisco, USA treated 37 aggressive mandibular lesions (25 
keratocyts, 8 ameloblastomas, 2 giant cell tumors and 2 myxomas) with 
cryosurgery. No recurrences were seen after a mean follow-up of 75 months. 143 
Aboulafia et al (1994) Washington, USA described a technique for treatment of 
large subchondral tumors around the knee which extended to within two 
millimeter of the articular surface. Curettage, cryosurgery and composite 
reconstruction with bone graft, bone cement and osteosynthesis was used as an 
alternative to primary joint sacrificing resection. Out of nine tumors (six giant cell 
tumors, one chondroblastoma, one chondrosarcoma and one fibrosarcoma) there 
was one recurrence, retreated in the same fashion. All 9 patients had an 
excellent functional outcome. Only two patients had mild degenerative cartilage
changes.144
Marcove (1994) New York, USA treated four patients with giant cell tumor of the 
sacrum with curettage and cryosurgery and three with limited excision and 
cryosurgery. Two had local recurrence and two had positive second look biopsy 
with microscopic tumor all treated successfully with second cryosurgical 
procedures.145
Salmassy et al (1995) San Francisco, USA reviewed 20 patients with aggressive 
mandibular lesions treated with curettage and cryosurgery. Ten patients received 
an additional autogenous bone graft and ten did not. None of the patients with an
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additional bone graft suffered a complication. In the non-bone grafting group two 
pathologic fractures occurred, both in lesions with a diameter larger than 4.0
cm.146
CONCLUSIONS
From the above mentioned experimental data it is clear that cryosurgery is by far 
the most effective method of producing bone necrosis when compared to bone 
cement and phenol. It is therefore a valuable adjuvant, enabling an extended 
surgical margin in almost every benign and low-grade malignant skeletal tumor. 
Acceptable disease control with local recurrence rates of 15% or less can be 
achieved.
Its use as primary treatment without resection for carefully selected malignant 
tumors, e.g. chordoma should still be considered experimental.
Experiments in animals showed that the remodelling of frozen bone, resulting in 
normal strength takes about 3 to 6 months. This observation has been clinically 
borne out as evidenced by a high postcryosurgical fracture rate in many authors' 
early reports.
Experience and improvements in technique have reduced the fracture rate to an 
acceptable level. The rate of other complications such as wound dehiscence and 
infection compare favorably to other treatments.
Although some experimental evidence suggests that articular cartilage is 
irreversibly damaged by cryosurgery, this has only been partially substantiated in 
clinical series.
If nerves are frozen their function is only temporary impaired. Most neuropraxias 
resulting from freezing will resolve in 6 weeks to 6 months.147 Very likely 
regenerating nerve fibers can grow down the nerve sheaths since they are left 
intact. Furthermore the vital nerve cell nucleus is located away in the dorsal root 
ganglion.
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CHAPTER 6 
THE TREATMENT OF SIMPLE BONE CYSTS IN 
CHILDREN WITH CURETTAGE AND CRYOSURGERY
H.W.Bart Schreuder MD1, Ernest U. Conrad III MD2, James D. Bruckner MD2, 
Andrew T.G. Howlett MS3 and Lyle S. Sorensen MD2.
1 Orthopaedic surgeon, Department of Orthopaedics, University Hospital Nijmegen.
2 Orthopaedic sugeons, Bone Tumor Clinic, Department of Pediatric Orthopedics, Children's Hospita l 
and Medical Center, Seattle, WA, USA.
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ABSTRACT
A retrospective study in children with simple or unicameral bone cysts treated 
with curettage, cryosurgery and bone grafting was conducted. The purpose of this 
study was to evaluate local tumor control and bony healing following this method 
of treatment. Five of 42 (12%) treated patients suffered a local recurrence with a 
mean clinical follow-up of 24.5 months. Surgical complications consisted of two 
superficial wound infections, one radial nerve palsy and two fractures which all 
resolved completely.
A review of the literature was performed to compare our results to historical 
controls utilizing steroid injection therapy and curettage with bone grafting alone. 
We believe that the use of cryosurgery as adjuvant therapy in the surgical 
treatment of simple bone cysts is of value in controlling local recurrences and 
achieving bony consolidation.
INTRODUCTION
Simple bone cyst is a tumor of bone of unknown origin. It tends to occur in the 
metaphyses of long bones, particularly of the humerus and femur. Although 
histological completely benign, it frequently weakens the integrity of bone 
resulting in pathological fracture, which is often the presenting feature. The 
treatment options for simple bone cysts (SBC) include observation, injection and 
surgical curettage. Until Scaglietti et al introduced the technique of steroid 
injections,1,2 the most prevalent treatment method for SBC has been curettage 
followed by bone grafting with recurrent rates that vary from 12 to 48%.3-12 
Adjuvant therapy after curettage has been advocated to destroy residual tumor 
cells and lower tumor recurrence. In theory adjuvant treatments include
*In press: Journal of Pediatric Orthopaedics
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radiotherapy, cytotoxic physicals like phenol and hypertonic saline, merthiolate, 
cement and cryosurgery. The purpose of this study is to evaluate local tumor 
control and bony healing following the treatment of simple bone cysts with 
curettage, cryosurgery and allograft bone grafting. A review of the literature is 
included and our results are compared to historical controls.
MATERIALS AND METHODS
A retrospective study of all patients with a simple bone cyst treated in our 
institution was carried out including a review of all patient records, radiographs 
and pathology reports. The diagnosis of a simple bone cysts was made when 
membranous tissue was found within the cyst or when the cyst was found to 
contain no tissue at all. The cysts may or may not have contained serous or 
serosanguineous fluid. Cysts containing tissue consistent with aneurysmal bone 
cyst were excluded. Fiftythree patients were subsequently diagnosed with simple 
bone cyst and treated with curettage, cryosurgery and bone grafting between 
1989 and 1996. Eleven patients were treated in 1995 and excluded for follow-up 
of less than 12 months, leaving 42 patients in this study.
The following clinical parameters were assessed for each patient: age, sex, 
history and previous treatment, anatomic location, pathology results, 
postoperative complications and function and length of follow-up. Radiographs 
were reviewed in order to determine anatomic location, presence of pathological 
fracture, cyst size (greatest diameter), postoperative osseous healing and the 
presence of local recurrence. Staging was accomplished using the radiographic 
criteria for benign lesions of bone defined by Enneking.13 
The operative treatment of SBC in our patient group consisted of intralesional 
curettage via bony fenestration followed by cryotherapy and bone grafting. 
Cryotherapy or cryosurgery was performed using an apparatus (KryosprayRII, 
Brymill Corporation, Vernon CT, USA) producing a liquid nitrogen spray by which 
the osseous cavity was frozen and then thawed using a warm saline solution. 
Three cycles of freezing and thawing were carried out after a limited curettage 
executed by curettes and a mechanical burr. The bony defect was then filled with 
allogenic freeze dried bone chips, which were procured and processed according 
to guidelines recommended by the American Association of Tissue Banks.14 Care 
was taken not to damage the adjacent physis by curettage and if the physis was 
exposed to the cyst, it was separated from freezing by several layers of surgical 
gelfoam. When possible, tourniquets were used. For all lower extremity lesions, 
postoperative full weightbearing was not allowed for approximately 6-12 weeks. 
Follow-up was achieved by clinical examination and routine radiographs at 1-2 
month intervals until bony healing. The results of our treatment were evaluated 
radiographically using the following classification terminology, modified from a 
system previously utilized by Neer et al3,10:
A. complete response: the space occupied by the cyst is completely filled with 
new bone formation with remodelling or consolidation of the bone graft.
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Figure 6.1 : Simple Bone Cyst of the humerus in an 11 year old girl. Preoperative radiograph s
showing pathological fracture (A,B). Postoperative radiographs at two months after curettage ,
cryosurgery and bone grafting (C,D), and at 13 months demonstrating complete consolidation o f 
the grafted site and humeral remodelling (E,F).
Figure 6.2: Simple Bone Cyst of the humerus in a 12 year old boy. Preoperative radiograph s
showing displaced pathologic fracture (A,B). Postoperative radiographs at two months showing a
small early recurrence at the lateral cortex (C,D), and at four months showing progression of th e 
local recurrence, which was subsequently treated (E,F).
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B. partial response: small areas (<1.0 cm) of radiographic lucencies are seen 
within the boundaries of the previous cyst which otherwise demonstrates 
complete bone formation and remodelling of the graft. With continued 
radiographic follow-up no increase in size of these lucencies are recognized 
over time.
C. local recurrence: radiographic lucency, within or adjacent to the prior cyst 
that enlarges radiographically over time.
D. no response: no radiographic evidence of bony healing following injection. 
This response is applicable only to patients who have been treated with 
steroid injection(s).
The treatment results of the historical controls collected from the literature were 
also reviewed and scored using this classification system. Statistical significance 
to identify patient related factors affecting recurrence was determinated by using 
chi-square analysis.
RESULTS
Our patient group consisted of 31 (74%) males and 11 (26%) females. Eighteen 
(43%) patients were younger than 11 years of age and 24 (57%) were between
11 and 20 years of age (Table 6.1). The mean age at which the first operation 
was performed using cryosurgery was 11 years (range 3-18). The anatomical 
distribution of the affected sites in our and published series is listed in Table 6.2. 
In our series the humerus accounted for 71% of the cases. Previous treatment 
had been carried out in 16 (38%) patients involving one or more injections with 
steroids in 11 (26%) patients, curettage with bone grafting in 4 (10%) patients 
and one (2%) patient had received both treatments. Pain was the presenting 
factor in six (14%) patients and a pathological fracture in 33 (79%) patients, with 
multiple fractures in eight of those 33 patients. Patients with fractures all had 
radiographic signs of cortical thinning and endosteal erosion and were all staged 
according to Enneking's criteria as active benign tumors.13 The mean longitudinal 
length of cyst in long bones was 6.2 centimeters (range 1-13). The mean clinical 
follow-up was 24.5 months (range: 13-64). A "complete response" to treatment 
(Figure 6.1) was observed in 21 (50%) patients and a "partial response" in 16 
(38%) patients. Five (12%) patients suffered a local recurrence (Figure 6.2) and 
were subsequently further treated as summarized in Table 6.4. All patients, 
except one were controlled with a second similar surgical treatment. 
Postoperative complications included two superficial wound infections involving 
serous wound drainage, which resolved within ten days with oral antibiotics. One 
patient with a humeral diaphyseal SBC suffered a transient partial radial nerve 
palsy postoperatively which resolved over six weeks without deficit. Two patients 
suffered nondisplaced postoperative fractures, that occurred following accidents. 
Both fractures healed with conservative treatment. Limb length discrepancies of 
more than two centimeters were not observed. All patients, including those who 
had successful treatment of local recurrence had excellent function of the treated
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limb recorded during their follow-up exams. No specific patient-cyst 
characteristics (age, gender, size, previous treatment and pathological fracture) 
could be identified as significant risk factor for a local recurrence, when 
evaluated by chi-square analysis (P<0.05).
Author, 
reference #
N male female
age
pathologic 
fracture (%)0-10 I 11-20 I 21-30 I >30
Campanacci, 3 416 295 121 54 312 Í 42 8 45
Inoue, 6 23 15 j 8 j 7 11 j 2 3 22
Oppenheim, 7 53 43 ; 10 ; 74% between 5 and 15 years* 83
Spence, 8 144 103 j 41 j 94% < 19 years* > 50%*
Spence, 9 177 134 Í 43 j 124 49 3 1 -
Neer, 10 175 120 j 55 j - - - - fem: 100% 
hum: 87%
Bovill, 4 32 17 ; 15 ; 70% between 5-15 years * 75
Mylle, 11 59 37 ; 22 ; mean 15 years* 36
Morton, 12 76 51 j 25 j 37 24 6 9 58
Scalietti, 1 163 111;  52 ; > 16 months and < 17 years * 45
Pentimalli, 15 40 26 j 14 j 17 23 - - 95
Schreuder 42 31 11 18 24 - - 79
Total # patients: 1400 983 417 259 443 53 21
66%Percentages o f totals: 70% 30% 33% 57% 7% 3%
Table 6.1: Data accrued from the literature review of 1400 patients with a diagnosis of simple bone cyst or 
an equivalent diagnosis ( * data not used in totals).
DISCUSSION
The diagnosis of simple bone cyst (SBC) or unicameral bone cyst (UBC) was first 
described as a specific entity by Virchow in 1876.8 Typically it refers to a 
membrane-lined cyst, often filled with clear or serosanguinous fluid of low 
viscosity. Many cysts do have trabecular loculations, making the term 
multiloculated cyst also applicable to many cysts. Radiographically a SBC is a 
central, lucent lesion located in the metaphysis or at the junction of the 
metaphysis and diaphysis. In younger children it may be located directly adjacent
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to the physis. The cyst frequently produces endosteal cortical erosion and is not 
often associated with some limited expansion of the bony diameter. This 
expansion makes its radiographic distinction from an aneurysmal bone cyst 
difficult.
Author, 
reference #
N proximal
metaphysis
humerus
diaphysis
humerus
femur tibia fibula cal­
caneus
other
Campanacci, 3 416 198 79 116 7 2 5 9
Inoue, 6 23 8 4 3 1 - 1 6
Oppenheim, 7 53 32 - 14 4 1 - 2
Spence, 8 144 77 - 38 12 1 5 11
Spence, 9 177 101 - 47 6 3 9 11
Neer, 10 175 94 - 31 20 4 5 21
Bovill, 4 32 17 14 - - - - 1
Mylle, 11 59 22 - 19 1 2 5 10
Morton, 12 76 25 8 22 - - - 21
Scalietti, 1 163 68 23 40 7 5 7 3
Pentimalli, 5 40 16 11 9 3 1 - -
Schreuder 42 11 19 1 3 2 4 2
Total: 1400 669 144 354 64 21 41 107
Percentages o f totals: 47% 10% 25% 5% 2% 3% 8%
Table 6.2: Anatomical distribution of simple bone cysts. The result of data accrued from literature review.
Histologically, the cyst is lined by a soft tissue membrane with proliferating 
fibroblasts and occasional giant cells. SBC has been proposed to be a 
posttraumatic lesion resulting from the failure of absorption of an intra-osseous 
hematoma.15 Others believe the cyst represents the inability of the interstitial fluid 
to escape from the bone due to blockage in the venous drainage system16,17 and 
treatment have been directed toward decreasing the intra-osseous pressure.18,19 
Mirra et al believes that the cysts represent an interosseous synovial cyst, based 
on electron microscopic analysis of cyst membranes.20 High levels of oxygen 
scavengers have been isolated in SBC fluid and implicated in the associated 
bone destruction.21
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The demographic characteristics of our series do not differ significantly from the 
typical picture demonstrated in the literature for SBC. The majority (57%) of 
patients in the literature with SBC are between the ages of 11 and 20 years, 33% 
are younger than 11 years old and 10% involves patients older than 20 years 
(Table 6.1). There is a clear male predominance: 70% against 30% females 
(Table 6.1). Fiftyseven percent of the cysts are located in the humerus and 25% 
in the femur. SBC frequently presents with a pathological fracture (68%), often 
due to a minimal trauma (Table 6.1). Pain without radiographic evidence of 
fracture is the second most common presentation, while the rest are discovered 
incidently. When a fracture is present, normal fracture healing will occur and in a 
small percentage of cases the SBC may heal, however most SBC's will recur 
without treatment and are at risk for a second fracture.16,22 Our series of patients 
with SBC was exceptional only in the relatively high number of humeral cysts and 
a slightly higher fracture incidence.
Treatment alternatives for SBC in the past have most commonly included steroid 
injection or operative curettage. Because recurrences following curettage alone 
remain significant, several forms of local adjuvant treatment have been tried. 
Phenol as an adjuvant treatment after intralesional curettage of SBC has been 
reported with a recurrence rate of 20%.10,23,24 Cementation, or the use of cement 
is another form of adjuvant treatment utilized in the past for giant cell tumor.25,26 
To our knowledge no data is available on its use as an adjuvant for SBC. 
Marcove used cryosurgery as adjuvant treatment in 23 patients with a SBC and 
recorded 2 (9%) recurrences.27
We have summarized the published results of the treatment of SBC in Table 6.3. 
As reasonably possible, the literature treatment results has been classified into
A,B,C and D categories as has our own series. The distinction between a 
"complete response" (A) and a "partial response" (B) is subject to potential intra- 
and interobserver bias. The categories of "local recurrence" (C) and "no 
response" (D) represent patients requiring further treatment. As described by this 
review of the literature, curettage with bone grafting for SBC is associated with 
an overall mean recurrence rate of 29% (range 12-48%). Using cryosurgery as 
local adjuvant therapy we have been able to achieve a recurrence rate of 12% (5 
out of 42 patients).
Scaglietti et al introduced the technique of steroid injection, which remains widely 
employed.1 In his initial series, 76% of the patients failed to respond after the first 
injection and required more injections. On the average, three to four injections 
over a period of 12 to 20 months were needed to achieve complete healing in 
55% with "rare recurrences" and partial healing in 45% associated with a higher 
recurrence rate.1,2 Other series have reported local recurrence together with no 
response following injection as high as 25%.3,4 The disadvantage of steroid 
injections include the need for repeated injections and multiple visits for follow-up 
over long periods of time. Its ability to produce a completely healed bony defect 
remains poorly defined. The advantage of injections is the minor extent of the 
treatment and its minimal associated morbidity.
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Cryosurgery using liquid nitrogen has been utilized in orthopaedic oncology for 
the treatment of benign active and aggressive tumors.27,28
Author 
reference #:
treatment and result respectively recurrence
follow-up
y=year
m=month comments
steroid injection curettage ± bonegraft
N A B C D N A B C
Campanacci, 3 141 71 36 21 13 178 83 38 57 1-35 y multiple inj.
Inoue, 6 23 18 2 3 15-39 m graft: hydroxy- 
apatite cubes
Oppenheim, 7 18 15 2 1 - 33 20 1 12 6 m - 12 y 50% > 1 inj.
Spence, 8 144 98 10 36 12 - 48 m crushed cortical- 
bone allograft
Spence, 9 177 97 16 64 7 - 156 m cancellous-bone
allograft
Neer, 10 133 80 20 33 > 24 m 40% with zinc 
chloride/phenol
Bovill, 4 12 6 3 1 2 15 5 3 7 mean 5.6 y 42% > 1 inj.
Mylle, 11 20 5 13 1 1 21 5 6 10 mean 8.5 y in curet. group: 2 
hydroxyapat.
Morton, 12 58 52* - 6 27% < 1 y 13 no graft, 29 
allo, 16 autograft
Scalietti, 1 163 90+ 73+ - - - - - - > 3 y 3-4 inj. 12-20m
Pentimalli, 5 20 14 5 1 - 20 5 12 3 14.9 y 1-5 inj, allo- and 
autografts
Total: 374 201 132 25 16 802 463 108 231
Percentages: 54% 35% 7% 4% 58% 13% 29%
Table 6.3: Treatment results from published series. In reviewing these articles we have utilized ou r 
modification of the original Neer classification of treatment results (A,B,C and D; see text) for simple bon e 
cysts. The definition has been applied consistently to patients treated with steroid injection or curettage ( * 
= not specified in A or B, + = recurrences mentioned but not quantified).
This form of adjuvant treatment is delivered by spraying liquid nitrogen into the 
curettaged cavity in order to extend the surgical margin. The associated 
temperature injury will kill residual tumor cells.
Basic research has been done to investigate the extent of histological changes in 
frozen bone segments in vivo. Malawer et al showed in experiments with dogs
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that liquid nitrogen was capable of inducing trabecular and bone necrosis, 
extending 7-12 mm around the circumference of a cavity representing a bone 
cyst.29 The minimum temperature necessary for a cytotoxic effect is believed to 
be -50 to -60 C for invasive cancer cells 30 and rapid cooling (more than 100 
degrees per minute) increases cell death.31 In some centers cryosurgery is 
utilized by pouring liquid nitrogen directly into the bony cavity. A spray delivery 
was used in this series because it enables increased contact of the coolant with 
the irregular walls of the cavity and allows better appreciation and control of the 
extent of the freeze.
Although the benefit of the cryosurgical technique has been recognized for some 
time, it has not been practiced widely in orthopaedic oncology. This is due to 
limited experience and concerns regarding a high incidence of complications.32,33 
While complications due to nitrogen embolism have been reported, they were not 
observed in our patients.27,34 One patient in our series did suffer a partial radial 
nerve palsy that completely resolved spontaneously. We agree with Marcove that 
the complication rate has been significantly lowered with greater experience.26 
All patients except two in this series had their bony defect grafted with allogenic 
bone chips. In general, bony healing was rapid and relatively complete.35 There 
were no cases of postoperative osteolysis which were not associated with tumor 
recurrence. We did not recognize any other complications attributed to the use of 
this graft material. Patients and their families were carefully informed regarding 
the small risk of potential disease transmission with allogenic bone grafts and all 
patients receiving allograft, consented to its use. Based on this experience we 
continue to encourage patients and their families to consider allogenic freeze- 
dried chips as the graft of choice.
patient age
year
gender site size
cm
time to recurrence outcome
firs second third
JL 8 female diaphysis humerus 5 23 - - A
GB 6 male prox. metaph. humerus 4.5 4 9 - OR scheduled
CJ 11 male diaphysis humerus 5 4 8 - A
PM 8 male diaphysis femur 4 11 11 8 A
SB 16 male prox. metaph. humerus 9 4 - - A
Table 6.4: Survey of patients with local recurrence, further treatment and outcome.
We believe that the use of cryosurgery as an adjuvant therapy in the surgical 
treatment of SBC is of significant value. Using this technique we have 
experienced a local recurrence rate of 12%, which is lower than the overall mean 
recurrence rate of published series of 29% for curettage and bone grafting. Local 
recurrences that did occur were typically recognized (4 out of 5) within twelve 
months after surgery. These results were achieved in a group of patients who had
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a relatively high fracture rate and had failed prior treatment in 38% of the 
patients. Considering this relatively high risk group of patients we think that our 
local tumor control represents an improvement over past published techniques.
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ABSTRACT
We treated 26 patients with 27 aneurysmal bone cysts by curettage and 
cryotherapy and evaluated local tumour control, complications and functional 
outcome. The mean follow-up time was 47 months (19-154). There was local 
recurrence in one patient. Two patients developed deep wound infections and 
one had a postoperative fracture.
We compared our results with previous reports in which several different 
methods of treatment had been used and concluded that curettage with adjuvant 
cryotherapy had similar results to those of marginal resection, and that no major 
bony reconstruction was required.
We recommend the use of cryotherapy as an adjuvant to the surgical treatment 
of aneurysmal bone cysts. It provides local tumour control. Combination with 
bone grafting achieved consolidation of the lesion in all our patients.
INTRODUCTION
Aneurysmal bone cyst is a rare benign tumour-like lesion of bone of unknown 
origin. There is controversy as to whether it is a distinctive radiological and 
pathological entity or a pathophysiological change superimposed on a pre­
existing lesion.1 Lack of understanding about its origin and growth makes 
treatment empirical. The most common treatment has been curettage with bone 
grafting which has a substantial rate of recurrence.2-6 Lower recurrence rates can 
be achieved by marginal or wide resection, but are accompanied by loss of bone
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and the need for reconstruction.2,7,8 Intralesional resection or curettage with 
effective adjuvant therapy to extend the surgical margin has been advocated.5,9 
Since 1969 we have used cryotherapy as an adjuvant therapy after intralesional 
resection and we now evalute our results.
PATIENTS AND METHODS
We performed a retrospective study of all patients treated for aneurysmal bone 
cyst between 1969 and 1995. This included review of all patient records, 
radiographs and pathology reports. The diagnosis had been made on both 
radiological and histological examination. Only patients with the diagnosis 
aneurysmal bone cyst and no other abnormal histological findings were included. 
There were 12 females and 14 males (27 aneurysmal bone cysts). The mean age 
at which cryotherapy was first performed was 21.7 years (4.2 - 49.6) and the 
distribution is shown in Table 7.1. The bones involved are shown in Table 7.2.
All had been treated by curettage and cryotherapy. Age, gender, history, 
anatomical location, tissue pathology, complications, function after surgery and 
length of follow-up had been recorded. Staging was accomplished using the 
radiological criteria for benign lesions of bone defined by Enneking.10
Author N male femal age (years)
0-10 11-20 21-30 31-40 41-50 > 51
Campanacci et al2 198 83 115 63 94 20 12 8 1
Koskinen et al11 20 13 7 3 9 2 3 2 1
Martinez and Sissons'2 87 45 42 25 39 14 3 2 4
Morton13 26 14 12 12 6 4 2 2 -
Nobler et al14 33 13 20 3 - 17 7 6 -
Ruiter et al6 105 46 59 39 50 13 2 - 1
Szendröi et al8 52 31 21 15 25 6 2 1 3
Vergel De Dios et al15 238 109 129 57 132 30 6 6 7
Schreuder et al 26 14
(54%)
12
(46%)
5
(19%)
10
(38%)
5
(19%)
2
(8%)
4
(15%)
-
Total 785 368 417 222 365 111 39 31 17
Percentages o f totals: 46.9 53.1 28.3 46.4 14.1 5.0 3.9 2.2
Table 7.1: Details of studies on aneurysmal bone cysts.
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Operative treatment consisted of intralesional resection (curettage) after bony 
fenestration, followed by cryotherapy. Initially, this had been used by one (2 
cases), two (4 cases) or three (2 cases) freeze/thaw cycles, pouring liquid 
nitrogen into the bony cavity. In the subsequent 19 cases, we used three cycles 
of freezing and spontaneous thawing with a machine which produced a liquid 
nitrogen spray. The progress of freezing was usually monitored by 
thermocouples. A temperature of less than -50oC inside the cavity was 
considered to be lethal for remaining tumour cells. A thermocouple outside the 
cavity, preferably close to the neurovascular bundle, was used to prevent 
freezing of these structures. In many cases the cavity was filled with an autograft 
(4) or allograft (14) of bone. Spondylodesis was performed once. Preoperative 
antibiotic prophylaxis was used in all patients (Kefzol; Eli Lilly Nederland BV, 
Nieuwegein, The Netherlands).
Occlusive tourniquets were not used. Patients were not allowed to bear weight on 
the affected limb until there were signs of radiological consolidation.
The mean clinical follow-up was 47.4 months (19-154). Two patients had a 
follow-up of less than 24 months (19 and 22). Conventional plain radiography 
was used in the follow-up period. Functional assessment was performed at the 
most recent follow-up visit and consisted of operation-related complaints and 
physical examination.
Author tibia femur vertebra pelvis humerus fibula foot hand ulna+r 
adius
other N
Biesecker e t17 8 8 4 8 14 3 6 2 6 7 66
Campanacci et a l2 48 35 20 28 15 14 8 8 9 13 198
Cole7 5 2 - 6 4 2 - - 4 2 25
Farcetti et a l18 1 5 2 - - 1 4 - 2 5 20
Koskinen et a l11 3 3 1 2 6 2 1 - 1 1 20
Martinez et a l12 19 12 13 8 6 4 5 5 10 5 87
Morton13 6 5 5 1 1 3 3 - 1 1 26
Nobler et a l14 4 6 2 7 3 1 4 - 3 3 33
Ruiter et al6 15 13 14 8 7 11 7 10 5 15 105
Szendröi8 8 6 4 7 8 5 4 2 6 2- 52
Vergel De Dios et a l15 34 40 34 26 14 18 13 15 15 29 238
Schreuder et al 6 8 2 3 4 2 2 - - - 27
22% 30% 7% 11% 15% 7% 7%
Total 157 143 101 104 82 66 57 42 62 73 897
Percentage: 17.5 15.9 11.2 11.6 9.1 7.3 6.3 4.7 6.9 9.2
Table 7.2: Anatomical distribution of aneurysmal bone cysts.
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RESULTS
We classified 11 aneurysmal bone cysts as aggressive and 16 as active. The 
presenting symptom was a pathological fracture in seven patients, pain or 
discomfort due to swelling in 17 patients and neurological symptoms in two (both 
of whom had vertebral lesions). There was only one local recurrence, a rate of 
3.7%. This cyst had been treated with only one cycle of cryotherapy using the 
pouring technique.
Complications included two cases of deep wound infections (7.4%). Both were 
successfully treated by debridement and the implantation and subsequent 
removal of gentamicin-PMMA beads. After a fall due to breakage of a crutch 
handle one patient had a femoral fracture through the treated lesion; this was 
treated successfully by osteosynthesis. One patient with a sacral lesion had a 
temporary increase in neurological symptoms which resolved within three 
months. All bone grafts showed progressive consolidation and incorporation. At 
the most recent follow-up, 24 patients had normal function of the treated limb 
without discomfort. One had some loss of movement at the hip and one at the 
ankle. All patients resumed normal daily activities.
DISCUSSION
Aneurysmal bone cysts is common in adolescents and almost half of the patients 
are between 10 and 21 years of age.2,6,8,11'15 There is a slight predilection for 
females (Table 7.1), and great varibility in the clinical course. In most cases there 
is pain and swelling and sometimes a pathologic fracture. When located in the 
vertebral column neurological symptoms, as well as pain, are likely to be present. 
Aneurysmal bone cysts can occur in any bone, bur are more common in the 
metaphysis of the long bones, especially around the knee, and in the vertebral 
column (Table 7.2). The demographic characteristics of our series do not differ 
significantly from the typical picture reported in the literature.
Aneurysmal bone cysts both erode and cause "expansion" of underlying 
cancellous and cortical bone.2 Around the lesion there is always a shell formed by 
periosteal new bone and, although this may be only millimeters thick, it prevents 
direct extension into the soft tissues.16
The concept of aneurysmal bone cyst as a secondary phenomenon occurring in a 
preexisting lesion is based on the fact that in approximately one-third of the 
cases a pre-existing lesion can be identified, the most common of which is giant 
cell tumour.1 Others are osteoblastoma, angioma and chondroblastoma.1,12,17 
Less common assosiations include fibrous dysplasia, non-ossifying fibroma, 
chondromyxoid fibroma, solitary bone cyst, fibrous histiocytoma, eosinophilic 
granuloma, radiation osteitis and trauma. Malignant lesions, such as 
osteosarcoma (especially telangiectatic), fibrosarcoma and metastatic carcinoma 
may have similar radiological and histological features to aneurysmal bone cyst,6 
so accurate diagnosis is essential before advising treatment.
Author
irradiation curettage + 
irradiation
curettage + or 
- bonegraft
curettage + 
cryosurgery
marginal
resection
wide
resection
mean
follow-up
(months)
time to firs t recur­
rence 
(months)N R N R N R N R N R N R
Campanacci et a l2 8 2 15 3 91 19 - - 47 0 - - 84 2-72
Cole7 - - 1 0 18 7 - - 4 0 2 0 > 24 75% < 24
Clough and Price3 1 0 2 0 15 8 - - 3 0 - - 79 5-48
Farcetti et a l18 - - 3 0 11 2 - - - - 6 0 116 3-4
Freiberg et al4 - - - - 7 5 - - - - - - > 24 < 14
Koskinen et a l11 - - 1 0 14 2 - - - - 5 0 54 -
Kreicbergs et a l19 - - - - 21 8 - - - - - - > 24 -
van Loon et a l20 1 0 - - 8 3 - - - - 1 0 102 7-15
Marcove et a l5 11 1 - - 44 26 51 9 - - - - 85 3-102
Nobler et a l14 6 1 1 0 18 6 - - 4 2 4 0 - -
Ruiter et al6 2 0 - - 82 28 - - 17 4 4 0 80% > 24 -
Slowick et a l21 4 0 - - 5 1 - - - - 4 0 83 10
Szendröi et a l8 - - - - 26 7 - - 6 0 16 0 > 24 14
Vergel De Dios et a l15 1 0 12 2 124 27 - - - - 17 0 > 24 90% <24
Schreuder et al - - - - - - 27 1 - - - - 47 36
Total: 34 4 36 5 484 149 78 10 81 6 59 0
Recurrence rates (%): 11.8% 13.8% 30.8% 12.8% 7.4% 0%
Table 7.3: Different types of treatment (N) and recurrence tates (R) of aneurysmal bone cysts.
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We agree with the view that aneurysmal bone cyst is an entity on its own2 having 
unique clinical, radiological and diagnostic behavior. The diagnosis should be 
made only after the exclusion of an underlying lesion which can produce similar 
features. Such other conditions should be labelled after their principal element 
with the added description "cystic or hemorrhagic changes".2 Our study included 
only primary aneurysmal bone cysts with no other histological findings.
Because of this lack of understanding about the origin and growth of aneurysmal 
bone cysts a variety of treatments has been described. They include irradiation 
alone, or a primary surgical approach with or without some kind of adjuvant 
treatment. Theoretically, adjuvant therapy may consist of systemic 
chemotherapy, radiotherapy and physical adjuvants like phenol, hypertonic saline 
merthiolate, polymethylmethacrylate (PMMA) cement applied locally, and 
cryotherapy.
Chemotherapy and irradiation therapy have an effect on mitotically-active cells. 
Their influence on a benign lesion such as aneurysmal bone cyst is limited and 
we believe that they are inappropriate because of the side-effects. Although 
radiation therapy has been used, especially in sites of difficult surgical access, 
with good results (Table 7.3), we do not advise it because of the risk of 
secondary sarcoma in the irradiated field.
Phenol is a non-selective cytotoxic agent and when applied directly to the 
surface of curetted tumours, it kills remaining residual tumour and normal cells. 
Used as an adjuvant after curettage of aneurysmal bone cysts, the reported 
recurrence rate is 12.5% to 20%.22,23 Recurrence is probably due to its superficial 
action and the impossibility of penetrating the periphery beyond surgical margin. 
The rationale of the use of PMMA cement as adjuvant treatment is based on its 
heating effect. Experiments have shown that a thermal lesion of at least 50oC is 
necessary for a cytotoxic effect. The maximum peripheral extent of a thermal 
lesion varies from 2.5 mm in cancellous to only 0.5 mm in cortical bone.24 For 
local control of giant-cell tumour good results with recurrence rates of 5% to 15% 
have been reported,24,25 but no results are available for the use of PMMA cement 
as adjuvant treatment of aneurysmal bone cysts.
The most commonly used treatments and their recurrence rates are summarized 
in Table 7.3. The recurrence rate for irradiation with or without curettage are 
similar, respectively 11.8% and 13.8%. Curettage with or without bone grafting is 
accompanied by a high recurrence rate of 30.8%. Cryotherapy as an adjuvant 
after curettage has a recurrence rate of 12.8%. Marginal and wide resection are 
associated with low recurrence rates, 7.4% and 0% respectively. In review of 65 
cases of aneurysmal bone cysts in the facial region,26 curettage was associated 
with a recurrence rate of 33%, about the same as for non-facial lesions. 
Cryotherapy using liquid nitrogen has been used for the treatment of benign 
stage-2 (active), stage-3 (aggressive) and low-grade malignant stage IA skeletal 
tumours.27-30 It is often advocated to avoid extensive surgical destruction of 
tissue.26-30 Intralesional resection is performed by curettage. Adjuvant treatment 
is currently given by spraying liquid nitrogen into the bony cavity. This method
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Figure 7.1: Initial antero-posterior (A) and lateral (B) radiographs of an aneurysmal bone cyst in the 
proxima l metaphysis of the left humerus of a four-year-old-boy three months after curettage , 
cryotherapy and bone allograft (C and D). One year (E and F) and four years (G and H) the bon e 
has completely remodelled and the appearance of the intramedullary space is almost normal.
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must be considered marginal by oncologic principles.10 The advantage, 
compared with local resection, is that the supportive function of bone is 
preserved and reconstructive surgery can be limited. In studies on the extent of 
the effect of freezing on bone segments in vivo, Gage31 found that the 
temperature gradient was steep and that at approximately 2 cm from the freezing 
source no freezing of bone occurred, even after 15 minutes of freezing. All the 
frozen bone was devitalized within one week. Osteogenesis originating from 
normal bone and periosteum adjacent to the frozen segment, however, was seen 
within several days. Revitalization by simultaneous resorption and reossification 
took several months.31,32 The minimum temperature necessary for a cytotoxic 
effect on invasive cancer cells is believed to be -50oC to -60oC.33 Rapid cooling 
(more than 100o/min) and slow thawing (1oC to 10oC/min) allows the highest cell 
death rates.32,34 The freeze and thaw cycles must be repeated several times 
because living tissue is able to resist thermal injury and it is technically difficult to 
achieve optimal conditions for cell death in all areas of the lesions. To 
compensate, repetition of freeze thaw cycles is a practical solution and is safe 
especially at the periphery of the lesion.34-36 In the early days of cryotherapy liquid 
nitrogen was poured directly into a curetted tumour cavity.28 We prefer spraying 
liquid nitrogen, in every direction needed, because it increases the contact area 
with the irregular walls of the cavity, and the freezing process is more easily 
controlled.
Although the cryotherapeutic technique and its potential benefits have been 
known for a long time, it is infrequently adopted in orthopaedic practice. This is 
probably due to the high incidence of complications, especially postoperative 
fractures and wound infections, that have been reported.26,28 Among our patients 
there was one postoperative fracture due to trauma. There were two deep 
infections which needed additional surgery. We do not use tourniquets, in order 
to keep nerves and skin vascularized and thereby protect them from freezing 
injury. Nerve injuries appear to recover completely. Gas embolism is possible, 
and there has been one reported mortality.29,37 The complication rate becomes 
less as experience with cryotherapy increases.27
We found that cryotherapy as an adjuvant to curettage of aneurysmal bone cysts 
is associated with a local recurrence rate of 4%. The only recurrence we had was 
probably due to technique as only one cycle of cryotherapy had been used. 
Marcove et al5 reported a recurrence rate of 18% which after additional 
treatments with the same technique decreased to 4%. Marginal and wide 
resection of aneurysmal bone cysts lead to comparable local control, but more 
extensive reconstructive surgery is then needed, with associated morbidity. In 
general, we recommend the use of cryotherapy as an adjuvant to curettage for 
the treatment of aneurysmal bone cysts (Figure 7.1). The use of a bone graft 
allowed for consolidation in all cases. In expendable bones (e.g. proximal fibula, 
ribs) marginal resection appears to be sufficient.2 Superselective embolization 
with or without irradiation may be considered for aneurysmal bone cysts located 
in anatomic positions which are very difficult to treat surgically, like vertebral and
sacral lesions.2,8,14
Cryosurgery for aneurysmal bone cysts 6 9
REFERENCES
1 K ransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, an d 
imaging. Am J Roentgenol 1995; 164: 573-80.
2 Campanacci M, Capanna R, Picci P.Unicameral and aneurysmal bone cysts.
Clin Orthop 1986; 204: 25-36.
3 Clough JR, Price CHG. Aneurysmal bone cysts: Pathogenesis and long term results of treatment . 
Clin Orthop 1973; 97: 52-63.
4 Freiberg AA, Loder RT, Heidelberger KP, Hensinger RN.Aneurysmal bone cysts in youn g 
children. J Pediatr Orthop 1994; 14: 86-91.
5 Marcove RC, Sheth DS, Takemoto S, Healey JH.The treatment of aneurysmal bone cyst.
Clin Orthop 1995; 311: 157-63.
6 Ruiter DJ, van Rijssel ThG, van der Velde EA.Aneurysmal bone cysts. A clinicopathological stud y 
of 105 cases. Cancer 1977; 39: 2231-9.
7 Cole WG. Treatment of aneurysmal bone cysts in childhood. J Pediatr Orthop 1986; 6: 326-9.
8 Szendrö i M, Cser I, Konya A, Renyi-Vamos A.Aneurysmal bone cyst. A review of 52 primary an d 
16 secondary cases. Arch Orthop Trauma Surg 1992; 111: 318-22.
9 Oeseburg HB, Rogge CWL, Schraffordt Koops H, O ldhoff J. Cryosurgical treatment o f 
aneurysmal bone cysts. J Surg Oncol 1978; 10: 9-20.
10 Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop 1986; 204: 9-24.
11 Koskinen EV, V isuri TI, Holmstrom T, Roukkula MA. Aneurysmal bone cyst: evaluation o f 
resection and of curettage in 20 cases. Clin Orthop 1976; 118: 136-46.
12 M artinez V, Sissons HA. Aneurysmal bone cysts. A review of 123 cases including primary lesion s 
and those secondary to other bone pathology. Cancer 1988; 61: 2291-2304.
13 Morton KS. Aneurysmal bone cyst: a review of 26 cases. Can J Surg 1986; 29: 110-5.
14 Nobler MP, Higinbotham NL, Phillips RF.The cure of aneurysmal bone cyst. Irradiation superior t o 
surgery in an analysis of 33 cases. Radiology 1968; 90: 1185-92.
15 Vergel De Dios AM, Bond JR, Shives TC, McLeod RA, Unni KK.Aneurysmal bone cyst. A 
clinicopathologic study of 238 cases. Cancer 1992; 69: 2921-31.
16 Enneking WF. Aneurysmal bone cyst.
In: Musculoskeletal Tumor Surgery. New York: Churchill Livingstone, 1983: 1513-29.
17 Biesecker JL, Marcove RC, Huvos AG, Miké V.Aneurysmal bone cysts. A clinicopathologic stud y 
of 66 cases. Cancer 1970; 26: 615-25.
18 Farsetti P, Tudisco C, Rosa M, Pentimalli G, Ippolito E.Aneurysmal bone cyst. Long-ter m 
follow-up of 20 cases. Arch Orthop Trauma Surg 1990; 109: 221-3.
19 K re icbergs A, Lonnqvist PA, Nilsson B. Curettage of benign lesions of bone. Factors related t o 
recurrence. Int Orthop 1985; 8: 287-94.
20 van Loon CJM, Veth RPH, Pruszczynski M, van Horn JR, Lemmens JAM Aneurysmal bone 
cyst. Long-term results and functional evaluation of 16 primary cases in 13 patients.
Acta Orthop Belgica 1995; 61: 199-204.
21 Slow ick FA Jr, CampbellCJ, Kettelkamp DB.Aneurysmal bone cyst. An analysis of thirteen cases . 
J Bone Joint Surg Am 1968; 50: 1142-51.
22 Schiller CH, Ritschl P, W indhager R, Kropej D, Kotz R.Frequency of recurrence in phenolized and 
nonphenolized bone cavities following intralesional excisions of nonmalignant bone tumors.
Z Orthop 1989; 127: 398-401.
23 Capanna R, Sudanese A, Baldini N, Campanacci M .Phenol as an adjuvant in the control of loca l 
recurrence of benign neoplasms of bone treated by curettage.
Ital J Orthop Traumatol 1985; 11: 381-8.
24 Rock MG. Treatment of bone cysts and giant cell tumors.
Current Opinion in Orthopaedics 1990; 1: 423-34.
25 Malawer MM, Dunham W. Cryosurgery and acrylic cementation as surgical adjuncts in the treatment 
of aggressive (benign) bone tumors, Analysis of 25 patients below the age of 21.
Clin Orthop 1991; 262: 42-57.
26 Trent C, Byl FM. Aneurysmal bone cyst of the mandible.
Ann Otol Rhinol Laryngol 1993; 102: 917-24.
27 M arcove RC, Stovell PB, Huvos AG, Bullough PG.The use of cryosurgery in the treatment of lo w 
and medium grade chondrosarcoma. A preliminary report. Clin Orthop 1977; 122: 147-56.
7 0  Chapter 7
28 M arcove RC, Weis LD, Vaghaiwalla MR, Pearson R.Cryosurgery in the treatment of giant cel l 
tumors of bone. A report of 52 consecutive cases. Clin Orthop 1978; 134: 275-89.
29 Marcove RC. A 17-Year review of cryosurgery in the treatment of bone tumors.
Clin Orthop 1982; 163: 231-4.
30 Jacobs PA, Clemency Jr RE.The closed cryosurgical treatment of giant cell tumor.
Clin Orthop 1985; 192: 149-58.
31 Gage AA. Cryosurgery for cancer. Comprehensive Therapy 1984; 10: 61-9.
32 Kerschbaumer F, Russe W, Weiser G, Bauer RCryolesions of bone.
Arch Orthop Traumat Surg 1980; 96: 5-9.
33 Gage AA. What temperature is lethal for cells? J Dermatol Surg Oncol 1979; 5: 459-60.
34 Neel HB, Ketcham AS, Hammond WG.Requisites for successful cryogenic surgery of cancer.
Arch Surg 1971; 102: 45-9.
35 Gill W, Frazer J, Carter D.Repeated freeze-thaw cycles in cryosurgery.
Nature 1968; 219: 410-3.
36 Gage A. Experimental cryogenic injury of the palate: observations pertinent to cryosurgical destruction 
of tumors. Cryobiology 1978; 15: 415-25.
37 Schreuder HWB, van Beem HBH, Veth RPH.Venous gas embolism during cryosurgery for bon e 
tumors. J Surg Oncol 1995; 60: 196-200.
Cryosurgery for eosinophilic granuloma 71
CHAPTER 8
EOSINOPHILIC GRANULOMA OF BONE:
RESULTS OF TREATMENT WITH CURETTAGE, 
CRYOSURGERY AND BONE GRAFTING
H.W.Bart Schreuder1, Maciej Pruszczynski2, J. Albert M. Lemmens3,
René P.H. Veth4.
University Hospital Nijmegen, The Netherlands:
1 MD, Orthopaedic Surgeon, Department of Orthopaedics.
2 MD, PhD, Pathologist, Department of Pathology.
3 MD, PhD, Radiologist, Department of Radiology.
4 MD, PhD, Orthopaedic Surgeon, Professor of Orthopaedics, Department of Orthopaedics.
ABSTRACT
Intralesional instillation of steroids is currently the first choice of treatment for 
eosinophilic granuloma of bone. However, some lesions fail to respond or are 
unsuitable for injection therapy due its location, (pending) pathologic fracture and 
soft tissue intrusion. We treated six patients with these lesion characteristics with 
curettage, cryosurgery and bone grafting. After a mean follow-up of 23.3 months 
all lesion were completely healed, although one femoral fracture eight months 
after the operation occurred.
In selected cases of eosinophilic granuloma of bone a primary surgical treatment 
seems feasible. The use of cryosurgery as adjuvant treatment extends the 
surgical margin and is of value in avoiding local recurrence.
INTRODUCTION
Eosinophilic granuloma (EG) of bone is part of a spectrum of diseases known as 
Langerhans cell granulomatosis all characterized by proliferation of specific 
histiocytes, designated as Langerhans type, in normal tissue. These histocyte 
proliferations, called eosinophilic granuloma can occur unifocal, multifocal and be 
part of systemic illness known as the Hand-Schüller-Christian disease and 
Letterer-Siwe disease.1-3
The etiology is unknown and therefore its treatment is empirical. Eosinophilic 
granuloma of bone was most commonly treated with chemotherapy, surgery and 
irradiation.4,5 Currently, as in our institution, intralesional instillation of steroids is 
the first choice of treatment with good results.3,4,6-8 However, some lesions fail to 
respond to steroid injection therapy or are unsuitable for injection therapy due to 
their size, location, loss of bony containment and or soft tissue intrusion.
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Especially in case of cortical destruction with pending pathological fracture and 
possibly neurological damage in spinal cases.9-13 a primary surgical approach can 
be the treatment of choice. This study describes six of such patients in whom we 
performed an intralesional resection by curettage followed by cryosurgery. This 
local adjuvant treatment extends the surgical margin, without the need for 
segmental resection. Bone reconstruction is consequently limited and is achieved 
by auto- or homogeneous bone grafting.
PATIENTS AND METHODS
Six patients (4 males and 2 females) were diagnosed with EG of bone, all proven 
by biopsy prior to definite treatment. One patient was 23 year of age, the other 
were children with a mean age of 3.8 year (range: 1.0 -6.8). Five suffered a 
solitary lesion and one patient had multiple bony lesions, but without any 
systemic disease. The indications for surgical treatment were pending 
pathological fracture with loss of cortical containment in all four femoral lesions, 
one with no response to steroid injection, extreme aggressive behavior with 
cortical destruction and extensive soft tissue intrusion of an ulnar lesion 
threatening the integrity of the elbow joint. The 23 year old patient had EG in the 
body of a cervical vertebra (C4). This lesion was treated surgically and stabilized, 
because spinal locations are associated with collapse of the vertebral body 
(vertebra plana) with sometimes serious neurological complications.3,4,9-12,14 
Surgical treatment consisted of curettage of the lesion through cortical 
fenestration, three cycles of cryosurgery utilizing a spray or closed probe followed 
by spontaneous thawing. Reconstruction of the defect was done with chip 
homologous bone grafting in all long bone cases and the cervical case had an 
autologous strut bone graft.
In four cases local peroperative temperature monitoring using thermocouples 
mounted in a injection-like needle were used.
Post-operative follow-up was done using routine radiographs and skeletal 
surveys, magnetic resonance imaging and bone scans at standard intervals.
RESULTS
The mean follow-up of the six patients was 23.3 months (range: 10-47). In all 
cases the onset of symptoms was pain and functional impairment. Three of the 
four patients with femoral lesions healed completely, with full range of movement 
of the treated extremity (Figure 8.1). The fourth patient with a femoral lesion was 
mobilized with full weightbearing, but suffered a fracture eight months after 
curettage, cryosurgery and bone grafting, possibly due to a trauma. This fracture 
was initially treated conservatively, but because of progressive malunion,
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Figure 8.1: Anterior posterior radiographs of right femur of a 6 year old boy. Osteolytic lesion du e
to EG with pending pathologic fracture (A). After curettage, cryosurgery and homologous bon e
graft (B). Follow-up at six (C) and 33 (D) months. A complete normalization of the proximal femu r 
has occurred.
Figure 8.2: Anterior posterior radiographs of right femur of a 2 year old girl.
Osteolytic lesion due to EG, preoperative (A). After curettage, cryosurgery and homologous bone graf t 
(B). Follow-up at 5 months (C). Pathologic fracture 8 months after the operation (D). Consolidation 5 
months after internal fixation with plate and screws (E).
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osteosynthesis was performed (Figure 8.2), with satisfactory result. Extensive 
tissue samples taken during this procedure revealed no microscopically evidence 
for recurrent EG. All four patients with femoral lesions had no radiographic 
indications for local recurrence at their latest follow-up.
The patient with the ulnar lesion healed completely, with full range of motion of 
the elbow (Figure 8.3). The patient with the C4 lesion is symptom free with full 
range of motion 10 months after the treatment, with no evidence for local 
recurrence. Although the curetted body of C4 was reconstructed with a three 
cortical iliac crest bone graft a mild local kyphosis of approximately 15 degrees 
developed (Figure 8.4).
In addition to the mentioned fracture there were no complications. 
DISCUSSION
Eosinophilic granuloma represents fewer than one percent of all bone tumor like 
lesions and its etiology remains unknown.2,3,15 In contrast to other benign bone 
lesions its predilection sites are the skull and ribs.2,4,15-17 However, its occurrence 
in long bones and spine is frequent enough to pose difficulties in diagnosis, in 
part of radiologic variability.2,4,15 Males are predominantly affected and in general 
the lesions occur in the first decade of life, patients beyond 30 years are 
exceptional.2,15,17,18
Patients with EG of bone frequently present with local pain, tender swelling, 
functional impairment and occasionally with a (pending) pathological
fracture.3,4,8,15,17
A major problem in this disorder is the possibility of misdiagnosis.17 The 
differential diagnosis includes chronic infection and malignant bone tumors like 
Ewing sarcoma and osteosarcoma in children and adolescents, in adults other 
primary bone tumors, myeloma, malignant lymphoma (Hodgkin) and metastatic 
disease.2,3,15
Treatment modalities described for EG are curettage,2,4,15,16 radiotherapy15,17 and 
chemotherapy5 and combinations of these modalities.5,15,16,19 Radiotherapy is 
effective,20 although second primary neoplasm have been reported.4,18 Therefore 
its use should be limited to sites difficult accessible to surgery.
The rational of intralesional injection with corticosteroids is based on the 
assumption that EG is an (auto)immunologic disorder.6,15,17 This treatment is 
effective, safe and convenient with only little reported complications.3,6,8,15 
Patients with only local or multifocal disease involving only the skeleton have an 
excellent prognosis,14 multiple sites of soft tissue involvement is not unfavorable, 
as long as the liver is spared.16,21-24
We treated six patients with EG of bone surgically, because we felt that these 
lesions, as explained earlier, were unsuitable for corticosteroid injection therapy. 
The use of cryosurgery as local adjuvant treatment to intralesional curettage 
extends the surgical margin. By this method the procedure can be considered to 
be marginal from the point of view of orthopaedic oncologic principles.25
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Figure 8.3: Anterior posterior and lateral radiographs of left elbow of a 3.5 year old boy. EG lesio n 
close to joint (A,B). Follow-up at 7 months after curettage, cryosurgery and homologous bone graft 
(C,D) and at 15 months (E).
Figure 8.4: Lateral radiograph of cervical spine of 23 year old man. Lytic lesion of body C4 (A). T 1 
weighed magnetic resonance image, partial collapse of body (B). Follow-up at 4 months afte r 
curettage, cryosurgery and autologous strut bone graft (C) and at 10 months (D).
7 6  Chapter 8
The advantage of this kind of treatment, as compared to local segmental 
resection, is that as much as possible of the supportive function of bone is 
preserved and thatreconstructive surgery can be limited. In orthopaedic oncology 
it is used for the treatment of benign and low-grade malignant stage IA skeletal 
tumors.25-33
Basic research on animals has been done to investigate the histological changes 
of bone segments in vivo. Histologically all the frozen bone is devitalized within 
one week after the freeze. On the other hand, osteogenesis originated from 
normal bone and periosteum adjacent to the previously frozen segment, was 
seen within several days.34 The revitalization by simultaneous resorption and re­
ossification took several months.34,35 The minimum temperature necessary for a 
lethal effect is believed to be minus 50 to 60 Celsius for invasive cancer cells.36 
Rapid cooling (more than 100 degrees per minute) and slow thawing (1-10 
degrees per minute) facilitates the highest cell death rates.35,37 It is necessary to 
repeat the freeze and thaw cycles several times because living tissue is capable 
of resisting thermal injury and it is technically difficult to achieve optimal 
conditions for cell death in all areas of the lesions. To compensate, repetition of 
freeze thaw cycles is a practical solution and creates safety especially at the 
periphery of the lesion.37,38
In the cervical spine case, with the vicinity of the spinal cord, a closed cryoprobe 
was used because the extent of the freezing-process is more easily controlled. In 
general we use a machine producing a liquid nitrogen spray, which increases the 
contact of the coolant with the irregular walls of the curetted lesion.
The use of cryosurgery as adjuvant therapy to curettage for EG of bone is to our 
knowledge only reported before by Marcove.39 He treated 4 patients and 
encountered, as we did, no local recurrent disease.
We conclude that in selected cases a primary surgical treatment of EG is 
justified, especially in case of a pending pathologic fracture of weightbearing 
bones. The additional use of cryosurgery to an intralesional resection of the 
tumor is of value in order to diminish the risk for local recurrence.
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ABSTRACT:
We describe a bilateral retinoblastoma survivor known for a germline mutation of 
the retinoblastoma susceptibility gene, who developed after 25 years a 
chondrosarcoma grade 1 and two aggressive enchondromas in the same femur. 
In lieu of segmental en block resection which would necessitates a technical 
demanding reconstruction, the patient was treated with intralesional resection, 
cryosurgery and bone grafting of all three lesions. After a follow-up of 30 months 
complete consolidation was observed with no evidence for recurrence.
Since bilateral retinoblastoma survivors have a 15 to 20% risk of developing a 
second, non-ocular, primary neoplasm in either an irradiated or nonirradiated 
field, the resected material was analyzed for DNA mutations by loss of 
heterozygosity analysis, single strand conformation polymorphism analysis, two­
dimensional DNA electrophoresis and sequencing. As expected, the germline of 
the RB1 gene was also found in the tumor, but no other mutations. To our 
knowledge this is the first bilateral retinoblastoma survivor ever reported who 
developed a chondrosarcoma grade 1 and two enchondromas in the same 
nonirridiated femur.
'Submitted: Journal of Bone and Joint Surgery (Am)
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INTRODUCTION
In 100 years retinoblastoma has changed from an almost fatal disease to one in 
which 95% percent of patients can be cured.1 In 25 to 30% the disease is bilateral 
and patients always carry a predisposing mutation in the retinoblastoma (RB1) 
susceptibility gene.2 Patients with bilateral retinoblastoma have a 15 to 20% risk 
of developing a second, non-ocular, primary neoplasm in either an irradiated or 
nonirradiated field.2-4 For a long time it has been supposed that these secondary 
tumors were caused by radiotherapy, but it is now known that they may appear 
outside the irradiated region and, more important, independent of irradiation. The 
most common tumor developing in a nonirradiated field is osteogenic sarcoma.5 
A variety of other second primary tumors like Ewing Sarcoma,6,7 melanoma,8 
pinealoma,2 rhabdomyosarcoma,9 leiomyosarcoma, fibrosarcoma, liposarcoma,10 
lymphoma11 and epithelioid tumors12 have been reported. We present a bilateral 
retinoblastoma survivor in whom after 25 years a chondrosarcoma and two 
enchondromas in the same femur were diagnosed.
CASE REPORT
A 26 year old female was referred because of patello-femoral pain of the left 
knee during exercise. General and specific physical examination revealed no 
serious abnormalities. Conventional radiographs of the knee were normal. The 
patient was known for bilateral retinoblastoma for which at the age of one year an 
excision of the right eye and irradiation therapy for the left eye was performed. 
She is the only known member of a family with a germline mutation of the RB1 
gene, being a deletion of cytosine in codon 796 in exon 23, leading to a 
premature stopcodon and thus to a truncated Rb protein. The remainder of her 
medical history is noncontributory.
Because of the high incidence of a second primary neoplasm in patients who 
survived bilateral retinoblastoma, a skeletal scintigraphy with technetium 99m 
was performed. At the site of the left knee no increased uptake of technetium 
was observed. Accidently three "hot spots" in the right femur were detected. One 
lesion was located in the distal part of the diaphysis, one in the distal metaphysis 
and one in the intertrochanteric area of the proximal metaphysis of the right 
femur. Inspection of specific X-rays revealed a mixed lytic and calcifying lesion 
of 2 by 3 centimeter in the distal part of the diaphysis of the right femur. MRI 
images of the mentioned sites showed evidence for tumors of chondroid origin 
(Figures 9.1A,B). A biopsy of the lesion in the distal part of the diaphysis was 
consistent with chondrosarcoma grade 1. The patient was treated with intra- 
capsular resection, cryosurgery and reconstruction with homologous bonechips of 
all three lesions. Although ill advised from an oncological point of view, because 
of potential contamination of the entire femur with tumor cells, it was re-enforced 
with an intramedullary nail (Figure 9.1C). The loadbearing capacity was impaired 
due to multiple resections and cryosurgery.
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Figure 9.1: MRI - T1 weighted, coronal view. The extent of the intramedullary lesions is accuratel y 
depicted. One lesion is located in the distal part of the diaphysis, one in the distal metaphysis (A) , 
and one intertrochanteric in the proximal metaphysis (B). After intralesional resection, cryosurger y 
and reconstruction with homogeneous bonechips of all three lesions an intramedullary nail i s 
introduced. The proximal locking screw was placed just proximal of the intertrochanteric lesion (C).
After removing of the nail, complete normalization of intramedullary space, no evidence fo r 
recurrences (D).
At the latest follow-up (30 months), normalization of the intramedullary space 
was observed with no evidence for recurrence (Figure 9.1 D). Histological 
analysis confirmed chondrosarcoma grade 1 in the previous biopsied lesion and 
enchondroma in proximal and distal metaphysis.
DNA isolated from the chondrosarcoma was analyzed for mutations. A 
comparison with leucocyte DNA using the polymorphic intragenic microsatellite 
markers RB1-2 and RB1-2013 showed that there was no loss of heterozygosity in 
the tumor. By single strand conformation polymorphism (SSCP) analysis14 all but 
exons 1 and 14 of the RB1 gene have been scanned for mutations, as well as the 
promoter region and the 3' untranslated part of the gene using newly developed 
PCR-primers except for the promoter region and exon 2 for which primers were 
synthesized.15 An aberrant pattern was only found for exon 23. Sequencing of 
that exon revealed as expected in one allele the deletion of a cytosine residue in 
codon 796 of the RB1 gene. All further exons except 1 and 14 have been 
completely sequenced using a cycle sequencing kit (Amersham) with M13-tailed 
primers. Two-dimensional DNA electrophoresis of all exons co-amplified by 
multiplex PCR after pre-amplification by long-distance PCR16 did not give any 
indication of further nucleotide variation.
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DISCUSSION
Diagnosing a chondrosarcoma grade 1 and two enchondromas in the same bone, 
we were faced with a difficult problem from a therapeutic point of view. We 
staged the chondrosarcoma as IA (= low-grade malignant, confined to one 
anatomical compartment) and both the enchondromas as stage 3 (= aggressive 
benign).17 As recommended treatment one might perform a local, preferably wide 
en bloc resection through normal tissue beyond the reactive zone of the tumor.17 
In our case, with three lesions spread in the femur multifocal resections of the 
femur and a technical difficult reconstruction with either endoprosthetic or 
massive allograft would have been necessary. In view of the potential morbidity 
of this procedure, the low-grade malignant features of this chondrosarcoma and 
aggressive but benign condition of the other lesions we chose for intracapsular 
resection of the three lesions, combined with cryosurgery as adjuvant therapy to 
extend the surgical margins. The value and effectiveness of cryosurgery as 
adjuvant therapy in orthopaedic oncology has been shown before.18-21 After an 
extended review of the literature from 1966 till 1996 using MEDLINE EXPRESS 
we were unable to find a report of chondrosarcoma in a clearly nonirradiated area 
in a patient treated for bilateral retinoblastoma. Chondrosarcoma has been 
reported in- or very close to the irradiated field in retinoblastoma survivors.22-24 
These chondrosarcomas are considered to be induced by the radiation therapy 
itself.
Our patient developed 25 years after excision of the right eye and irradiation of 
the left eye a second primary tumor. From the large series study of the Registry 
of Ophthalmic Pathology in AFIP it is not only known that the latency period for 
second nonocular primary tumors varies from 1,4 till 44,3 years (mean 13,4), but 
also that this period strongly depends on the length of follow-up.24 In some 
studies it has been found that after 20 years there is a sharp increase in the 
incidence of second primary tumors in the nonirradiated field in retinoblastoma 
survivors.2,4,10 The role of the RB1 gene in its relation with the high incidence of 
second primary tumors in retinoblastoma survivors is unclear. Furthermore, a 
RB1 mutation is found in 20 to 33% of the primary sarcomas in patients not 
known for retinoblastoma,25,26 including chondrosarcoma.27 
Using a combinations of methods that with the possible exception of the GC-rich 
exons 1 and 14 would certainly have detected a RB1 mutation when present, we 
could not find a second mutation besides the already identified germline 
mutation. Exons 1 and 14 were included in the all exon scanning for mutations by 
two-dimensional DNA electrophoresis, a method which to date never failed in 
detecting a whole series of known mutations in the CFTR gene,28 the RB1 gene16 
and the MSH2 and MLH1 genes.29 Although a definite and complete exclusion of 
RB1 involvement can never be ensured, the joint development of one 
chondrosarcoma and the two enchondromas in our patient will most likely be a 
consequence of dysregulation of one or more as yet unknown genes.
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ABSTRACT
Much controversy exists about the methods of evaluating, staging and final 
treatment of intramedullary chondroid lesions. This is particularly true for 
enchondroma and low-grade chondrosarcoma located in the extremities, because 
their accurate distinction is hampered by their radiographically and histologically 
similarity.
Since 1991 we treated 22 patients (mean age: 39.6 yrs) with 26 lesion (3 
chondroblastomas, 14 enchondromas and 9 chondrosarcomas grade 1) with 
curettage, cryosurgery and bone grafting. The preoperative assessment of these 
lesions and cryosurgical technique is described in detail.
After a mean follow-up of 25 months no recurrences were observed. 
Complications consisted of two postoperative fractures, one wound infection and 
one intra-operative venous gas embolism. All bone grafts incorporated resulting 
in full-weightbearing capacity and excellent functional results.
The combination of curettage and cryosurgery as adjuvant therapy is considered 
to be equal as marginal resection according to orthopaedic oncologic principles.
INTRODUCTION
Intramedullary chondroid lesions of bone include chondroblastoma, 
chondromyxoid fibroma, enchondroma and chondrosarcoma. In general 
chondroblastoma, chondromyxoid fibroma and chondrosarcoma grade 2 and 3 
do not pose major diagnostic problems. In contrast, the diagnostic distinction of 
enchondroma versus chondrosarcoma grade 1 is one of the most difficult areas
'Submitted: European Journal of Surgical Oncology
patient age gender location of lesions 1 histology * I final follow-up osteosyn­ MSTS comments
(years) 1 biopsy 1 resection staging (months) thesis score
1 45.1 M tibia: prox. metaphysis : B : C IA 34 plate 30 -
2 54.1 M femur: diaphysis : B : C IA 15 - 27 -
3 18.1 M humerus: prox. metaphysis ; D ; D 3 34 - 30 -
4 44.0 F 5th metacarpal ; a  ; A 3 40 - 30 -
5 38.1 F femur: diaphysis : B : C IA 30 - 28 fracture, developed 2nd primary 
chondrosarcoma grade 1 in scapula
6 36.5 M humerus: prox. metaphysis ; a  ; A 3 24 - 30 -
7 16.9 F tibia: prox. epiphysis ; D ; D 3 32 - 28 -
8 48.4 F tibia: dist. metaphysis : B : C IA 34 - 30 breast carcinoma
9 65.5 F fibula: prox. metaphysis : B : B 3 14 - 30 -
10 28.8 F femur: prox. metaphysis ; - ; A 3 33 nail 30
femur: dist. metaphysis ; - ; A 3 bilateral retinoblastoma survivor 
all lesions in the right femurfemur: diaphysis ; C ; C IA
11 47.3 M femur: diaphysis : B : A 3 16 - 26 fracture
12 57.3 F femur: distal metaphysis : B : B 3 27 - 30 -
13 20.5 F femur: prox. metaphysis ; a  ; A 3 25 - 30 Enchondromatosis; enchondroma rib, 
chondrosarcoma grade 1 ilium
14 50.1 M digit 1: first phalanx ; a  ; A 3 19 - 30
digit 2: first phalanx ; a  ; A 3
M. Ollierfibula: prox. metaphysis : B : C IA
15 28.5 F digit 4: first phalanx ; a  ; A 3 37 - 30 -
16 34.1 F femur: diaphysis : B : C IA 37 plate 30 -
17 24.9 M digit 2: first phalanx ; a  ; A 3 20 - 30 -
18 27.5 M trochanter major: epiphysis ; D ; D 3 14 - 30 -
19 56.5 F femur: prox. metaphysis : B : C IA 15 - 28 -
20 64.0 F femur: prox. metaphysis ; a  ; B 3 26 - 30 -
21 31.3 F femur: diaphysis : B : C IA 12 plate 30 -
22 35.3 F digit 3: first phalanx ; A ; A 3 12 - 30 -
Table 10.1: A: enchondroma, B: enchondroma, chondrosarcoma grade 1 not excluded, C: chondrosarcoma grade 1, D: chondroblastoma.
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of bone tumor pathology, where particularly close co-operation between 
pathologist, radiologist and orthopaedic surgeon is required.1 These diagnostic 
problems are the result of poorly defined criteria and subjective interpretation of 
clinical, radiological and histological features of enchondroma and 
chondrosarcoma grade 1.1-3 The continuous spectrum of biological behaviour of 
these entities is unpredictable and best illustrated by the fact that histological 
appearances of a cartilage tumor in the pelvis supporting the diagnosis of low- 
grade malignancy can be safely ignored when the lesion is located in the tubular 
bones of hands and feet.1,4,5 The correct diagnosis may further be troubled by 
sampling errors; histologic features of enchondroma and chondrosarcoma may 
coexist in the same lesion.
It is established that a benign tumor as enchondroma can undergo malignant 
transformation into secondary chondrosarcoma,3,6,7 especially in patients with 
multiple enchondromas as in Ollier disease and Maffuci syndrome.8 
Difficulty in diagnosis, potential malignancy, under and overdiagnosis may lead 
to uncertainty concerning the necessary treatment and the optimal extent of 
surgery. Because of low recurrence risk of enchondroma and low-grade 
chondrosarcoma in extremities, limited surgery with or without adjuvant therapy 
is advocated.9-11Since 1991, in our institution chondroblastoma, enchondroma 
and intramedullary low-grade chondrosarcoma are treated by intralesional 
resection, cryosurgery and bone grafting, originally described by Marcove.12 This 
paper emphasizes on our methods of evaluation and technique of treating these 
tumors and we evaluate results, complications and functional outcome.
METHODS AND PATIENTS
We conducted a study of patients with an intramedullary benign, stage 2 and 3 or 
low-grade malignant, stage IA chondroid tumor located in the extremity.13 Only 
patients with a minimal follow-up of 12 months or more are included in this study, 
leaving 22 patients with 26 lesions (two patients had three lesions). There were 8 
males and 14 females, mean age: 39.7 (range: 16.9-65.5).
At presentation a standard work-up was carried out. This included; history, 
physical examination, radiographs, total body bone scan, magnetic resonance 
imaging, biopsy, definite surgical treatment and protocolized follow-up.
Biopsy. Biopsy is carried out using an image intensifier to locate the most 
suspicious part of the lesion (lucent areas) and to document the exact location of 
the site biopsized. A trochar system capable of taking a sample consisting of 
cortex, intramedullary tissue and tumor was used. Usually cylindrical samples 
with a diameter of 5 mm and a length of one cm or more could be obtained. The 
biopsy should be made in such a way that it will not compromise any possible 
approach later utilized for definite treatment.
Radiographic evaluation: On plain radiography chondroblastoma appears as an 
oval or rounded, smoothly marginated, well-defined lucency with a thin, 
peripheral reactive osseous rim,14 usually situated in the apophysis of bone.
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Figure 10.1: The lesion in figure 1 is curetted resulting in a surgical margin (B), the spraying of 
liquid nitrogen (C) will result in an additional thermal injury inducing tissue necrosis extending 
beyond the borders of the lesion: the cryosurgical margin. The bony cavity is filled with a bone 
graft (D).
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Chondroblastoma may break through the cortex and invade a joint or adjacent 
soft tissues, which all can be assessed with CT and MRI.14 
Enchondroma and low-grade chondrosarcoma are usually located centrally in the 
metadiaphysis. Enchondroma appears as a oval lesion with a cartilaginous matrix 
mineralization including punctate, flocculent, or rings and arcs15 calcifications. In 
a narrow bone (hand) enchondroma frequently involves the entire width, causing 
expansion of the affected bone. Intramedullary low-grade chondrosarcoma has in 
addition to the features of enchondroma frequently lytic area(s) interspersed 
within the lesion. The cortex adjacent is often thinned (scalloping) or violated.16 
CT detects both subtle matrix mineralization and the integrity of the adjacent 
cortex, MRI is best for judging the extent of the lesion and these modalities will 
help in the radiographic distinction of enchondroma versus low-grade 
chondrosarcoma.17,18
Surgical technique. Standard orthopaedic oncologic exposures are used. When 
the exact location of a lesion or the proximity of a growth plate is unclear, an 
image intensifier is used. To avoid inadvertent freezing of the skin, wide 
retraction is mandatory. We never use extremity tourniquets, because normal 
circulation decreases the risk of freezing nearby neurovascular bundles and 
skin.Normally it is not necessary to dissect the neurovascular bundle away from 
the lesion to be frozen.
A sufficient oval window is made in the cortex using a drill or saw. The tumor is 
resected as thoroughly as possible using a curette (Figure 10.1B). Care is taken 
to avoid pushing tumor into the uninvolved medullary canal.
To monitor the intralesional temperature and local extent of the freeze, 
thermocouples are positioned in and around the lesion. A thermocouple placed 
adjacent to the neurovascular bundle will prevent inadvertent freezing by 
stopping the spraying of liquid nitrogen in time. Temperature data acquisition is 
done using a digital multimeter equipped with a thermocouple scanner card. 
Graphical real-time visualization of the course of the temperatures is done by 
connecting the multimeter to a personal computer (Chapter 11).
Cryosurgery is then performed (Figure 10.1C). Three cycles of cryosurgery are 
performed using a machine producing a liquid nitrogen spray (ERBOKRYO NL, 
ERBE, Nieuwegein, The Netherlands). This spray is directed in the lesion in 
every direction, until the whole cavity is wetted and becomes frosted. The 
nitrogen vapor, clouding the view is waved away by hand. The duration of each 
freeze is based on the temperature readings and visual observation. Intralesional 
temperatures of at least -50oC are pursued and necessary to induce tissue 
necrosis.19,20 Warming up until 20oC is done by spontaneous thawing.
Following the cryosurgery the entire wound and cavity is "washed" with sodium 
hypo-nitrate to prevent seeding of tumor cells.
The defect remaining after curettage and cryosurgery is filled with autograft or 
allograft bone chips. The cortical window is frozen as well and is replaced or used 
as a source of bone graft (Figure 10.1D).
A careful soft tissue reconstruction is very important, restoring the periosteum, if 
possible and covering the bone with muscle. A wound drain is always used and
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Figure 10.2: Routine radiographs of chondroblastoma (patient 3, table 10.1) located in proxima l
epiphysis of humerus (A,B). The lesion was painful, because of pathologic, minimal displace d
fracture of tuberculum majus. T1 weighted MRI studies, the extent of the lesion is accuratel y
depicted (C=coronal, D=transversal). Three (E,F), eight (G,H) and 30 months after curettage , 
cryosurgery and homologous bone grafting. Progressive incorporation and remodelling of the graft,
resulting in nearly normal bone structure at latest follow-up. No evidence of recurrence. Normal , 
pain free function.
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it should only be removed when drainage falls below 30 ml per 24 hours. Peri­
operative antibiotics are routinely used. If the strength of weightbearing bones, in 
particular the diaphysis of the femur, is compromised by the lesion and 
cryosurgery, prophylactic internal fixation is advised, using a plate and screws. 
An intramedullary enforcement is ill advised, because it has the risk of 
contaminating the entire intramedullary compartment with tumor cells. Partial 
weightbearing is usually necessary until three months after the operation. 
Histology. The histological diagnosis of chondrosarcoma grade 1 was made only 
when next to the cytological features an evident chondrosarcomatous pattern 
was present. This pattern shows hyaline or myxoid cartilage permeating lamellar 
bone (chondrosarcoma permeation pattern) replacing marrow fat (invasion of 
marrow fat pattern), bands of fibrosis and infiltration of Haversian system.3 The 
histological diagnosis had to be concurrent with the clinical and radiographical 
picture.
Follow-up. All patients had protocolized follow-up. Functional assessment was 
performed at the most recent follow-up visit and consisted of operation-related 
complaints and physical examination and scored according to the system for 
functional evaluation of surgical management of musculoskeletal tumors.21
RESULTS
Age and gender of the patients, the anatomical distribution, histological diagnosis 
of biopsy and subsequent resected material and final staging are shown in Table 
10.1. After definite treatment 17 lesions were staged as 3 (aggressive benign) 
and 9 as IA (low-grade malignant, intra-compartmental). Comparing histology 
results of biopsy versus resection, eight enchondroma were "upgraded" to a 
histology with preference for chondrosarcoma grade 1.
After a mean follow-up of 25 months (range: 12-40) none of the patients showed 
any evidence of a recurrence.
Two patients sustained postoperative pathological fracture (patients 5 and 11 in 
Table 1), both successfully healed with conservative treatment. One of them 
(patient number 5) had also a wound infection, which resolved after prolonged 
use of antibiotics. One patient suffered a venous gas embolism, which was noted 
because of hemodynamic instability during cryosurgery, without permanent 
damage. No neuro-vascular complications were experienced.
All bone grafts incorporated and remodelled resulting in full-weightbearing 
capacity in all patients (Figure 10.2, 10.3 and 10.4).
The mean MSTS score was 29.4 points (range: 26-30). All patients had excellent 
functional results and resumed their preoperative status of daily activities.
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Figure 10.3: Routine radiographs (A,B) of symptomatic enchondroma in diaphysis of femu r
(patient 16, table 10.1). T1 weighted MRI: coronal (C) and sagittal (D). On transversal (E) vie w
some endosteal reaction is seen. Two (F,G) and 37 (H,I) months after curettage, cryosurgery an d 
homologous bone graft. No evidence for recurrence.
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DISCUSSION
Much controversy exists about the methods of evaluating, staging and final 
treatment of an intramedullary chondroid lesion and this particular topic remains 
open for discussion. The reason for this controversy is partly due to the lack of 
hard criteria creating the possibility of differentiating radiologically benign 
enchondroma from low-grade chondrosarcoma. Furthermore, the histologic 
picture of benign enchondroma and chondrosarcoma grade 1 shows in more than 
25% of the cases complete overlapping concerning nuclear atypia, cellularity and 
number of double-nucleated cells, thus, the accurate distinction between 
enchondroma and well-differentiated chondrosarcoma is seriously hampered by 
their cytologic similarity3. The combined cytologic and histologic approach 
suggested by Sanerkin,22 later refined by Mirra et af3 to differentiate 
enchondroma versus low-grade chondrosarcoma has generally been adopted. It 
consists of pathohistologic characterizations distinguishing an enchondromatous 
pattern with "islands of cartilage" (islands of cartilage pattern) that are partially or 
completely surrounded by plates of lamellar bone and bone marrow 
(enchondroma encasement pattern "EEP") from a chondrosarcomatous pattern 
where hyaline or myxoid cartilage permeates lamellar bone (chondrosarcoma 
permeation pattern), replaces marrow fat (invasion of marrow fat pattern) and 
bands of fibrosis and infiltration of the Haversian system are seen.
Cytogenetic studies have not show a correlation between histological grade and 
chromosomal pattern of chondrosarcoma.23 Investigation of collagen types in the 
extracellular matrix of chondroid lesions showed alterations of collagen 
distribution to more immature types of collagen in low-grade chondrosarcoma.24 
In view of the diagnostic difficulties of chondroid lesions, generous material for 
biopsy is mandatory, and the use of clinical and radiographical evidence is 
critical to formulate the correct histological diagnosis.25
Concerning the treatment advised for benign, stage 3, enchondroma and low- 
grade chondrosarcoma, stage IA no consensus of opinion exists. Bauer et al 
concluded after a study of 40 patients with enchondroma and 40 with low-grade 
chondrosarcoma that limited surgery (curettage) is indicated because of low 
recurrence rates, respectively 0.04% and 0.09%.9 On the other hand Tsuchiya et 
al advises wide excision of borderline chondrosarcoma, in the same manner as 
low-grade chondrosarcoma.24 Sanerkin et al found that low-grade 
chondrosarcoma had a 5 year survival rate of 89%. Local recurrence rate was 
85%, strongly influenced by inadequate treatment, which was defined as 
resection with contaminated margins.26
Enneking states that enchondroma treated with curettage has a substantial 
recurrence rate and tend to extend beyond the margins of the original lesion. 
Recurrence after marginal excision is very low and nil after wide en block 
resection. However, he finds that in many clinical situations, these more 
aggressive procedures may produce a functional defect that is unacceptable 
considering the innocence of the disease. Clinical prudence frequently suggests 
an observational course following the diagnostic impression of enchondroma.27
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Figure 10.4: Radiographs of painful enchondroma (A,B) located in first phalanx of digit 3 (patien t
21, table 10.1). Periosteal reaction (arrow). T1 weighted MRI: coronal (C) and sagittal (D). Post -
operative view after curettage, cryosurgery and autologous bone graft, wound drain in situ (arrow) .
Seven weeks (F,G) and 12 months (H,I) postoperatively, progressive incorporation of bone graft , 
normal function.
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Campanacci advises treatment consisting of curettage, phenol and bone graft, 
only when enchondroma is symptomatic (pain) and have osteolytic areas on 
radiographs.28 For borderline cases of enchondroma versus low-grade 
chondrosarcoma aggressive intralesional resection followed by adjuvant 
treatment with phenol, cement or cryosurgery is allowed. All other forms of 
chondrosarcoma need resection with adequate margins.29 
Since biopsy may understate enchondroma and low-grade chondrosarcoma IA 
with hard to predict biological courses and histological diagnostic problems, it is 
our opinion that these lesions should be treated by marginal resection. Because 
this would imply en block resections in most cases with the associated morbidity 
and technical difficulties of reconstruction, we adopted the technique of curettage 
with adjuvant cryosurgery, which together is considered as marginal according to 
orthopaedic oncologic principles.13 The efficacy of this treatment has been shown 
for other skeletal lesions.30-33 In our series of patients with a mean follow-up of 25 
months we found no recurrences. For these specific type of tumors this follow-up 
period is short and our results may be classified as preliminary.
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ABSTRACT
Background: Cryosurgery is used in orthopaedic oncology as adjuvant treatment 
after intralesional resection of bone tumors to induce cell death at and beyond 
the surgical margin. Monitoring freeze/thaw cycles during cryosurgery is 
beneficial in controlling a cryosurgical procedure and in preventing an 
unwarranted local extent of the freeze.
Method: We conducted a study of 15 cryosurgical procedures with the use of a 
protocolized temperature measuring system with peroperative graphic 
visualization.
Results: Using a liquid nitrogen spray, intralesional temperatures of -150oC were 
achieved, which are, according to the literature, associated with cell death. 
Extralesional temperature measurements showed no subzero temperatures of 
surrounding important tissues.
Conclusions: Temperature recordings in and outside the lesion during 
cryosurgery in orthopaedic oncology are of importance to monitor the freeze/thaw 
cycles and are helpful in facilitating an effective cryosurgical procedure and in 
controlling the extent of the freeze, avoiding local complications.
INTRODUCTION
Cryosurgery utilizing liquid nitrogen is practiced in orthopaedic oncology for the 
treatment of primary benign and malignant bone tumors as well as for secondary 
metastases to bone. In benign and low-grade malignant stage IA skeletal tumors1 
it is used as an adjuvant treatment to intralesional resection (curettage) to extend 
the surgical margin of resection.2-10 By this method the procedure can be 
considered to be marginal according to oncologic principles.1 The advantage of 
this kind of treatment, as compared to local resection, is that as much as possible
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of the supportive function of bone is preserved and that reconstructive surgery 
can be limited.
In high grade sarcomas, cryosurgery has been used as the primary treatment 
with variable results.10,11 Cryosurgery used in the treatment of bony metastases 
has to be considered as palliative and in this respect helpful in local control of the 
malignancy.12,13
Since the introduction of cryosurgery in medicine, monitoring modalities have 
been developed to visualize the local process for the following reasons:
A. To ensure that lethal temperatures for tumor cell death are reached. The 
temperature of frozen tissue cannot be determined by its visual appearance 
alone, since frosted tissue looks the same at any freezing temperature.14,15
B. An accurate measurement of the depth and lateral spread of the freeze is 
necessary, not only for obtaining adequate margins, but also to avoid an 
unwarranted extension of the freezing inducing potential morbidity.15
C. Local temperature measurement enables a more precise determination of the 
ending of the thawing phase. Complete spontaneous warming up of the frozen 
tissue before the next freeze/thaw cycle is started is important to induce a 
maximum lethal effect on tumor cells.16
D. Monitoring, and preferably recording of the cryosurgical procedure, enables 
the physician to evaluate the procedure itself and interpret follow-up results 
with respect to the procedure. Adjustments in technique can be developed and 
introduced. Scientific research on recorded data will ultimately improve the 
quality of cryosurgery.
E. Recording of the whole freezing procedure provides written evidence, which 
may be of medicolegal importance.
Next to local monitoring, systemic monitoring seems to be of importance, 
because whenever a gas is introduced into a body cavity, there is always the 
hazard of intravascular introduction of gas bubbles. Gas emboli in the vascular 
circulation can cause serious hemodynamic complications and has been 
associated with potentially lethal circulatory and pulmonary complications.17-19 
Cryosurgery of bone tumors is in this perspective no exception and has been 
associated with (lethal) complications in the past.20,21
This report describes the technical details and results of local monitoring with 
thermocouples during cryosurgery of bone tumors (Figure 11.1A-D, 11.2A-D).
MATERIALS AND METHODS
For the local monitoring of cryosurgery of bone tumors, we developed a 
multifocal temperature measuring system utilizing up to nine thermocouples. The 
thermocouples consist of a copper/copper-nickel alloy and are mounted in the
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Figure 11.1 A,B,C and D: Routine radiographs of an 11-yr.-old boy with aneurysmal bone cyst i n
the distal tibia, very close to the growthplate (A,B). Magnetic resonance imaging, T2 (C) and T 1
(D), showing erosion of cortex and a fairly homogenous intensity of the contents of the cys t 
consistent with fluid.
Figure 11.2 A,B,C and D: Postbiopsy routine radiographs of a 29yr.-old female wit h
chondrosarcoma, grade 1 of diaphysis of diaphysis of the femur (A,B). Magnetic resonanc e
imaging, T1 (C) and T2 (D) weighed showing erosion of cortex and an inhomogeneous signa l 
intensity consistent with enchondroma or low-grade chondrosarcoma.
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tip of a 50-mm-long and 0.8-mm-diameter injection-like needle (Ellab A/S; 
Roedovre, Denmark). Their accuracy is better than 0.1oC with a response time of 
0.3 s. Temperature data acquisition was done using a digital multimeter (Digital 
multimeter 2000, Keithley Instruments, Cleveland, OH) equipped with a 
thermocouple scanner card (2001-TCSCAN, Keithley Instruments). Graphical 
real-time visualization of the course of the temperatures is accomplished by 
connecting the multimeter to a personal computer running appropriate 
"homemade" software. Next to performing real-time display, this program stores 
all temperature data for later analysis.
After exposure of the tumor, bony fenestration is performed followed by 
intralesional resection (curettage) of the tumor. Thermocouples are placed 
according to a fixed protocol: two to monitor the axial intramedullary spread of 
the freeze, respectively, proximal and distal of the lesion and two or more 
extracortical, around the lesion to monitor the lateral spread of the freeze. One 
thermocouple is situated in the lesion itself and reflects the intralesional surface 
temperature. Additional thermocouples can be used adjacent to structures that 
should not be damaged, such as neurovascular bundles and growth plates, or in 
joints to prevent damage of the articular cartilage. Intraoperative radiographs are 
used to document the location of the thermocouples more precisely (Figure 
11.1E,F and 11.2E,F).
Three cycles of cryosurgery are performed using a machine producing a liquid 
nitrogen spray (ERBOKRYO NL, ERBE, Nieuwegein, The Netherlands). The 
duration of each freeze is based on the temperature readings and visual 
observation. Warming up is done by spontaneous thawing. Reconstruction of the 
bony defect is carried out with an autologous and/or homologous bone graft 
(Figure 11.1G,H and 11.2G,H).
The protocolized temperature measurement system was used in 15 patients (5 
females, 10 males) with a mean age of 31.7 yrs (range 11-64), all having active 
or aggressive benign lesions,1 which are specified in Table 11.1.
Location/diagnosis humerus pelvis femur tibia radius total
GCT 1 1 2 4
ABC 1 1 2
SBC 3 1 4
chondroblastoma 1 1 2
enchondroma 3 3
Total: 5 1 1 5 2 j 2 15
Table 11.1: Anatomical distribution and diagnosis of 15 skeletal tumors treated with curettage, cryosurgery 
and bone grafting (GCT=giant cell tumor, ABC=aneurysmal bone cyst, SBC=simple bone cyst).
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RESULTS
Every patient had almost similar temperature recordings during their three 
freeze-thaw cycles. Two typical examples are shown in Figure 11.3A and 11.3B. 
In all cases the intralesional recording, which reflects the surface temperature of 
the bony cavity reaches -50oC in a mean time of 10.6 s (range: 8-15s) after the 
spraying with liquid nitrogen is started. A temperature of -150oC and below was 
easily achieved in all cases, with the exception of two giant cell tumors of the 
distal radius. Continuous spraying for 15-20 s resulted in an intralesional 
temperature of -50oC or below during a mean of 39.3 s (range: 22-88s). 
Spontaneous thawing between -50o and 0oC took on the average 152.6 s (range: 
30-420s). In this period the increasing temperature frequently entered a subzero 
plateaux phase varying in time from 20 s to 250s. Thawing from 0 to 20oC 
required in general 290 s (range: 90 to 900s). In Table 11.2 these monitoring 
readings are specified for, respectively, the first, second and third cycles. 
Thermocouples monitoring the axial and lateral spread of the freeze showed a 
delayed temperature decrease but it almost never dropped below 0oC.
The temperature recorded by the extracortical thermocouples, which are only 
separated from the freeze by the thickness of the cortex, sometimes declined just 
below 0o.
In general the whole area around the frozen lesion cooled down lengthening the 
time needed for thawing to 20oC after every freeze (Figure 11.3A,B).
Temperature phase 37oC -> -50oC -50oC and lower -50oC -> 0oC 0oC -> 20oC
Cycle 1 2 3 1 2 3 1 2 3 1 2 3
Mean time cycle (s) 9.5 11.5 10.7 40.1 36.0 41.7 136.8 165.0 156.0 221.7 294.3 354.0
Mean time 3 cycles (s) 10.6 39.3 152.6 290.0
Table 11.2 Temperature monitorings of 15 cryosurgical procedures included in this study. Mean time o f 
temperature phase per cycle (1,2 or 3) and of all 3 cycles (C=celsius, s=second).
DISCUSSION
The common practice of monitoring a cryosurgical procedure guided by the 
physician's clinical judgment and experience is found particularly in freezing soft 
tissue lesions. The progress of the treatment can be followed by observation and 
palpation, and the depth of freezing can be estimated by observing the lateral 
spread of freezing in the target tissue.15,22 Although clinical judgment of freezing 
extent is reasonably accurate, it is probably not enough to perform a controlled 
cryosurgical procedure when tissues with different thermal characteristics are 
involved. In orthopaedic oncology, these are cortical bone, intramedullary 
spongiosa, and soft tissues mainly muscle. To supplement clinical judgment
1 0 2  Chapter 11
Figure 11.1 E,F,F and H: Intraoperative radiographs showing localization of the temperatur e
couples. Number 2 and 3 are situated in the growthplate, number 4 is intra-articular (E,F). Th e
intralesional temperature couple, number 7 was added later. Numbers correspond with those i n
Figure 11.3A. After curettage and cryosurgery the cyst is filled with a homologous bone graf t 
(G,H).
Figure 11.2 E,F,G and H: Intra-operative radiographs showing localization of the temperatur e 
couples. Number 7 is situated in the curetted lesion. Numbers correspond with those in Figur e 
11.3B (E,F). After curettage and cryosurgery the cyst is filled with a homologous bone graft (G,H).
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Figure 11.3A: Temperature recordings of patient in Figure 11.1; numbers correspond with those in 
Figure 11. 1 E,F. The temperature measured by the thermocouples 1,4 and 6 were at all time s 
above 25oC. For reasons of clarity of the graph they are not shown.
temperatur« (Celsius)
50
200 '— 1---------------1— 1— 1— 1— 1— '— 1— 1-------------- 1— 1— 1— 1— ‘— 1— 1— *“
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36  38
time (minutes)
Figure 11.3B: Temperature recordings of patient in Figure 11.2; numbers correspond with those in 
Figure 11.2E,F. The temperature measured by the thermocouples 4,5 and 6 were at all time s 
above 10oC. For reasons of clarity of the graph they are not shown.
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during cryosurgery, a range of monitoring devices and techniques has been 
developed, most to address monitoring needs for specific applications of 
cryosurgery. Measurement modalities are thermography,23 which involves very 
expensive equipment and provides only surface freezing evaluation),15 
ultrasound,24,25 which is not suitable for bony tissue, and tissue impedance and 
resistance measurements,26-28 which causes concern about accuracy.16 
Computerized tomography29 and magnetic resonance30-32 are capable of 
visualizing frozen tissue, but their high cost and the logistics involved make them 
unsuitable for the orthopaedic setting. In this perspective we developed our 
system using temperature couples.
Thermocouples were first used to monitor cryosurgery of skin lesions. Their 
importance was recognized early in cryosurgical practice, particularly in 
establishing lethal temperatures.33
Using the temperature measuring system with real-time graphical visualization, 
we showed that with this freezing technique, intralesional temperatures of -150oC 
are achieved within seconds (freezing-rate > 10°C.s-1). Furthermore, the 
maintenance of a temperature of -50oC for 40 s, the apparent holding of this low 
temperature and the tissue in frozen state for 3 min, followed by spontaneous 
slow thawing and repetition of freeze/thaw cycles are all of importance to 
maximize tissue destruction.16,34
Using extralesional thermocouples we were able to show that important 
structures were not subjected to subzero, potentially damaging temperatures. 
Furthermore extralesional thermocouples enable the surgeon to optimize the 
duration and lateral spread of the freeze.
Extremely high freezing rates by spraying liquid nitrogen are achieved. These 
rates are associated with intracellular formation of ice crystals, inducing 
mechanical damage to the cell and thus cell death.34-38
After spraying has been stopped and thawing is allowed, the extralesional 
thermocouples show a further lowering of temperature, representing the 
retraction of tissue heat, which is used for the thawing of the more central parts 
of the frozen lesion. The nonlinear increase of the temperature in frozen tissue 
and its subzero plateau phase is explained by additional energy needed for the 
transition of ice into water, which halts the temperature increase temporarily. 
Figure 11.3 shows an almost identical pattern of the freeze/thaw cycles, 
indicating cryosurgery utilizing a spray is a reproducible method.
The accuracy of the thermocouple readings is important as the effectiveness of 
treatment partially depends on it. Proper calibration and reliable hardware (good 
quality of thermocouple, wiring, electrical connections, and display devices) are 
imperative. Even more critical is the correct placement of the thermocouple 
itself: a 1 mm variation in the thermocouple positioning can represent a 10-15oC 
temperature difference.39
In addition to routine systemic monitoring of the patient, end-tidal gas analysis is 
performed using a mass spectrometer measuring inspired and end-tidal O2, CO2, 
N2O, N2 tensions and anesthetic vapor concentration. Using real-time recording 
of the gas analysis breath by breath makes detection of any exhaled N2 possible,
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which is associated with venous nitrogen gas embolism. In this way, we hope to 
take appropriate action in time to prevent serious hemodynamic complications. 
Because we had cardiopulmonary complications in two patients, as reported 
earlier,21 we started to monitor our patients with peroperative transesophageal 
ultrasound of the heart. Using this method in five cases, we did not detect any 
venous gas embolisms during our cryosurgical procedures.
We conclude that temperature recordings in and outside the lesion during 
cryosurgery in orthopaedic oncology are of importance to monitor the freeze/thaw 
cycles and are very helpful in facilitating an effective, reproducible cryosurgical 
procedure and in controlling the extent of the freeze avoiding local complications. 
Systemic monitoring is of paramount significance for the safety of the patient.
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ABSTRACT
Cryosurgery using liquid nitrogen is a method for treating benign and low-grade 
malignant skeletal tumors. The advantage of preserving the supportive function 
of bone should be compared to the risk for its complications; postoperative 
fracture is well known, but less so the occurrence of intra-operative venous gas 
embolism. This paper describes 17 patients: 2 patients who had serious 
hemodynamic complications during cryosurgery and a study of 15 patients in 
whom end tidal N2 tension was measured in an attempt to investigate the clinical 
incidence of venous gas embolism during cryosurgery. In the 15 cases analyzed 
we did not detect any exhaled N2 during cryosurgery.
INTRODUCTION
Cryosurgery using liquid nitrogen has been practiced in orthopaedic oncology for 
the treatment of benign stage 2 skeletal tumors. In benign stage 3 and low-grade 
malignant stage IA skeletal tumors it is used in lieu of disabling wide 
procedures.1,2,3 Intra-lesional resection is performed first for instance by curettage 
of the tumor. In theory tumor cells may be left behind, which can be responsible 
for a recurrence of the tumor. Adjuvant treatment is given by spraying liquid 
nitrogen into the lesion to extend the surgical margin of resection. By this method 
the procedure can be considered to be marginal from the point of view of 
oncologic principles.1 The advantage of this kind of treatment, as compared to 
local resection, is that the supportive function of bone is preserved and that 
reconstructive surgery can be limited. The liquid nitrogen is sprayed into the bony 
cavity and since its boiling point is -195oC nitrogen bubbles are rapidly produced 
at room temperature. Whenever a gas is introduced into body cavity there is 
always the hazard of intravascular introduction of gas bubbles especially when 
pressure is allowed to develop. Gas emboli in the vascular circulation can cause
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serious hemodynamic complications.4,5,6 This paper demonstrates the hazards of 
the use of liquid nitrogen, although complications occurred in a limited amount of 
patients.
First, we describe two patients with hemodynamic complications during 
cryosurgery probably due to venous gas embolism. Because of our experiences 
with these two patients we conducted an additional study in 15 patients in whom 
end-tidal gas analysis was performed using a mass spectrometer measuring end- 
tidal nitrogen concentration during cryosurgery. Our aim was to get an impression 
of the clinical incidence of venous gas entry during cryosurgery in our institution.
CASE REPORT ONE
A 4-year-old, previously healthy boy, was suffering from an aneurysmal bone 
cyst proven by biopsy in his left proximal humerus (Figure 12.1). Definitive 
treatment was scheduled, which consisted of curettage of the cyst followed by 
spraying liquid nitrogen and homologous bone grafting.
Anesthesia was induced with halothane in oxygen inhalation, followed by 
thiopental 25 mg intravenously (iv), fentanyl 0,05 mg iv, vecuronium 2 mg iv, 
and 0.25 mg atropine iv. The patient was intubated and anesthesia maintained 
with
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Figure 12.1 (left): An aneurysmal bone cyst in the left proximal humerus before treatment. 
Figure 12.2 (right): Results of intra-operative monitoring case 1.
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halothane 1-2% inspired in nitrous oxide/oxygen 70/30%. Intraoperative 
monitoring included electrocardiogram, pulse oximetry, automatic noninvasive 
blood pressure measurement and continuous end-tidal capnometry. All 
monitoring values were recorded automatically on an ARKIVE patient data 
management system on a 1-min time scale.
During the first 58 min of surgery the cyst was exposed using an anterolateral 
exposure and the cyst was curettaged through a surgically made cortical defect 
measuring 2 X 2 cm. During this time the heart rate and blood pressure ranged 
between 70 and 80 beats per min (bpm) and 130/60 and 114/56 respectively. 
End-tidal CO2 tension was constant at 32 mm Hg. The digital pulse oximeter 
showed a constant 100% saturation. Vital signs and end-tidal CO2 tension 
remained normal and stable up to the time of cryosurgery.
Three cycles of spraying liquid nitrogen during approximately 20 seconds and an 
thawing period of approximately 3 min was performed. During the last cycle, just 
when the nitrogen spraying was stopped a decrease of the O2 saturation to 90% 
was noted. The blood pressure dropped to 70/40, together with a rise of the heart 
rate from 66 to 80 bpm. The end-tidal CO2 tension decreased to 15 mm Hg. 
Close inspection of patient and equipment revealed no other probable cause of 
this event but of venous gas embolism. Nitrous oxide and halothane were 
stopped and 100% of O2 was administered. Within a few minutes vital signs 
returned to normal and the condition of the patient stabilized (Figure 12.2). The 
humeral cavity was filled with a homologous bone graft and the surgical 
procedure was finished. The remainder of the anesthetic procedure was 
uneventful. The patient made a quick and complete recovery.
CASE REPORT TWO
A 26-year-old female was scheduled to undergo curettage of three 
chondrosarcoma grade I, stage IA lesions proven by biopsy in the right femur. 
One lesion was localized in the distal part of the diaphysis, one in the distal- and 
one in the proximal metaphysis of the right femur (Figure 12.3 and 12.4). The 
patient was known for bilateral retinoblastoma for which at the age of one year an 
excochleation of the right eye was performed and radiation therapy for the left 
eye. The remainder of her medical history was noncontributory. Pre-anesthetic 
medication consisted of midazolam 7.5 mg by mouth 1 hr before operation. 
Induction of anesthesia was performed with iv midazolam 2 mg, fentanyl 0,1 mg 
and vecuronium 5 mg iv. Maintenance of anesthesia was achieved with a 
continuous infusion of propofol and artificial ventilation with a nitrous oxide / 
oxygen mixture 70%/30%. Intraoperative monitoring consisted of 
electrocardiogram, digital pulse oximeter, automatic non-invasive blood pressure 
measurement and continuous end-tidal capnometry. After 60 minutes of surgery 
the three sites had been treated by curettage and were ready for spraying liquid 
nitrogen. So far the vital signs had been normal and stable. During the first cycle 
of cryosurgery the heart rate raised from 66 to 100 beats per minute. The blood
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pressure dropped to 90/40 mm Hg. The digital pulse oximeter showed a slight dip 
of the O2 saturation from 100 to 98%, but the end-tidal CO2 tension dropped to 13 
mm Hg. Immediately nitrous oxide was discontinued and the patient was 
ventilated with 100% oxygen. The presumptive diagnosis of venous gas 
embolism was made. Because the vital signs did not deteriorate but improved 
within a few minutes, no further measures were taken (Figure 12.5). The 
remainder of the surgery, anesthetic and the recovery was uneventful.
Figure 12.3 (left): MRI of the right femur showing chondroid lesions in the diaphysis and dista l 
metaphysis of the right femur. Figure 12.4 (right): MRI of the right femur showing chondroid lesion 
in the proximal metaphysis.
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Figure 12.5: Results of intra­
operative monitoring case 2.
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ADDITIONAL STUDY: PATIENTS AND METHODS
We used a mass spectrometer (Ohmeda Multi gas monitor 6000) to perform end 
tidal gas analysis in all patients who were treated by cryosurgery. The mass 
spectrometer measured inhaled and end-tidal O2, CO2, N2O, N2 tensions and 
anesthetic vapor concentration breath by breath, starting at induction and ending 
just after the patient's awakening. Real-time recording of the gas analysis results 
was achieved by connecting a personal computer to the RS 232 port of the mass- 
spectrometer. Usual anesthetic monitoring equipment was used consisting of 
electrocardiogram, digital pulse oximeter, automatic non-invasive blood pressure 
measurement and continuous end-tidal capnometry. We were able to perform 
gas analysis in 15 patients. All patients had general anesthesia with endotracheal 
intubation. Their sex, age, diagnosis and site of the tumor is summarized in 
Table 12.1.
Case no. Age (yr) sex diagnosis site
1 12 M benign fibrous histiocytoma distal metaphysis femur
2 34 M aggressive enchondroma proximal metaphysis humerus
3 6 M active unicameral bone cyst proximal metaphysis humerus
4 7 M histiocytosis X proximal metaphysis femur
5 28 M osteoblastoma distal metaphysis tibiae
6 68 F thyroid metastasis supra-acetabular part ilium
7 47 M lung metastasis proximal metaphysis femur
8 24 F giant cell tumor distal metaphysis ulna
9 20 M active bone cyst os ischiadicum
10 8 M active bone cyst distal metaphysis femur
11 43 M aneurysmal bone cyst diaphysis tibiae
12 7 F aneurysmal bone cyst proximal metaphysis tibiae
13 36 F chondrosarcoma diaphysis femur
14 16 M aneurysmal bone cyst proximal metaphysis humerus
15 32 F aneurysmal bone cyst talus
Table 12.1: Clinical data of 15 patients treated with cryosurgery for bone tumors.
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RESULTS
In the 15 cases analyzed, we did not detect any exhaled N2 during cryosurgery. 
Also, the measured O2, CO2, N2O tensions and anesthetic vapour concentration 
were completely normal. All patients had an uneventful course.
DISCUSSION
In the literature, one fatal case, probably due to venous gas embolism, has been 
described. The occurrence was explained by the blocking of the exit of gaseous 
nitrogen from the bone by intentional digital occlusion of the opening in the bone 
cortex.7
Dwyer et al. reported one case in which a dramatically increased end-tidal 
nitrogen tension was noted, but without any hemodynamic complications.8 These 
investigators estimated that the use of only 38 ml of liquid nitrogen will rapidly 
vaporize into approximately 27.4 L of N2 gas. So small amounts of liquid nitrogen 
can be responsible for a large volume (embolus) of intravascular gas.
Two dogs died because of cardiac arrest after liquid nitrogen was instilled into the 
mandibular marrow cavity. Resuscitation was unsuccessful and postmortem 
radiographs of the thorax showed air in the veins of the mediastinum, right atrium 
and ventricle.9
Our two patients showed signs of impairment of pulmonary circulation as 
indicated by a sudden significant drop in end tidal CO2 and corresponding 
changes in blood pressure and heart rate. We suggest that these features 
represent venous gas embolism because of their rapid development at the same 
time as the instillation of the liquid nitrogen and the fact that the symptoms 
disappeared rather quickly after the cryosurgery was ended. Solid particle 
embolism by marrow or fat is less likely, because this kind of embolism is 
provoked by mechanical elevation of the intramedullary pressure as in 
intramedullary nailing and introduction of a prosthesis.10,11 
We think that N2 bubbles are "pushed" into the venous circulation under influence 
of the pressure due to boiling of liquid nitrogen in the bony cavity. Dissolving N2 
in blood first is highly unlikely because of its very low Oswald solubility coefficient 
(C=0,015 at 37oC).
We are unable to estimate the amount of liquid N2 we are using in our cases. We 
are spraying and not pouring the liquid N2 into the bony cavity for as long we 
think is necessary to produce the required zone of subzero temperature. Based 
on the observations we made in two out of 17 patients, it seems that there may 
be a much higher risk of nitrogen gas embolism during cryosurgery, than might 
be gained from the only two reports in the literature. The risk is increased when 
the site of the tumor is located in a richly perfused area such as the metaphysis 
of the long bones where the major nutrient arterial and venous blood supply is 
entering the medullar cavity. Unfortunately, the metaphysis is the location of 
preference for many bony tumors suitable for cryosurgical treatment.
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Using cryosurgery one should never block the entrance to the bony cavity. 
Appropriate diagnostic monitoring (end-tidal CO2 or preferably N2 tension) should 
be in use. Nitrous oxide should be avoided as it potentially could increase the 
size of N2 bubbles. It might be wise to investigate the use of liquid oxygen or 
carbon dioxide which by its high solubility in blood is much less likely to produce 
pulmonary embolism.
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CHAPTER 13
SUMMARY AND CLOSING REMARKS
Active and aggressive benign and low-grade malignant skeletal tumors are 
commonly treated by intralesional curettage. Additional adjuvant treatment to 
extend the surgical margin is used to destroy tumor cells left behind, which 
otherwise may be responsible for a recurrence of the tumor.
This thesis describes the use of a specific type of locoregional adjuvant therapy: 
cryosurgery. It is the destruction of tissue in situ through the local influence of 
very low temperatures.
The following is a summary of this thesis. For discussion of the presented topics 
the reader is referred to the specific chapters. Finally, this paragraph is finished 
with closing remarks.
In c h a p te r  1 the aims of the thesis are posed; description of effective 
cryosurgery, review of the literature, evaluation of clinical results of cryosurgery 
for bone tumors and the development of equipment and results of local and 
general monitoring of cryosurgery are shown.
In chapter 2, it becomes clear that the therapeutic use of low temperatures has a 
long historical background and that it has found its way in almost every medical 
specialty.
Its anaesthetizing properties were first recognized. Later its benefits for the 
palliative treatment of malignancies was much appreciated. At that time the 
potential properties of very low temperatures for destroying tissue were 
recognized.
The development of suitable machinery for the application of very low 
temperatures to induce a cold injury to a specific target area of tissue, now 
known as cryotherapy or cryosurgery, gave the physicians a powerful tool in their 
armour for the treatment of benign and malignant tumors.
Using cryosurgery in modern medicine in general and for bone tumors in 
particular, it is necessary to investigate and formulate all basic factors and 
principles to perform a "state of the art" cryosurgical treatment.
The basic principles for effective cryosurgery for bone tumors are formulated in 
c h a p te r  3. Different kind of cryoprobes are compared and it is concluded that an 
open cryoprobe producing a liquid nitrogen spray has an extremely high cooling 
power (-175oC). It is the most suitable probe to freeze the irregular surface of 
bony cavities left behind after the curettage of bone tumors and is capable to 
achieve very rapid freezing rates.
Monitoring the cryosurgical process is of importance to ensure an effective 
treatment and to avoid an unwarranted extension of the freeze causing potential 
morbidity. Several monitoring devices are described and it is concluded that the
116 Chapter 13
local positioning of thermocouples mounted in the tip of a needle is the only 
practical solution for the monitoring of cryosurgery for the treatm ent of bone 
tumors.
Cryobiology; the study of physical effects of low tem peratures on living tissue is 
described in ch a p te r 4. It explains the lethal properties of a cold injury to an 
individual cell. It also directs the most effective method of cryosurgery; very rapid 
cooling which induces intracellular ice formation causing lethal mechanical 
dam age to cell m em branes, tem peratures as low as -50oC and slow thawing 
creating intracellular recrystallization of w ater and again mem brane dam age. 
Repetitive cycles of freezing and thawing is furthermore a prerequisite and is a 
practical solution to treat areas of insufficient freezing during previous cycles and 
to com pensate for the capability of living tissue to resist a therm al injury.
A literature review, with the intention to be complete, is presented in ch a p te r 5. 
Using M E D LIN E  E X P R E S S  1965 - 1996 all experimental and clinical data on 
cryosurgery with specific reference to the skeletal system are sum m arized. From  
this review it is concluded that frozen bone is devitalized within one week. 
Osteogenesis originating from normal bone and periosteum adjacent to the 
frozen segm ent is observed within several days. Revitalization of the dead bone 
by simultaneous resorption and reossification will take several months.
Studies on the efficacy of adjuvant therapies in terms of inducing additional 
peripheral necrosis after curettage showed that cryosurgery is superior as 
compared to phenolization and cementation.
The clinical use of cryosurgery on specific benign bone tumors, described in 
series of 25 patients or more, is very limited and conducted in less than 5 
different institutions. In terms of tumor control the results are good to excellent 
although the complication rates are high but diminish to acceptable figures 
according to the non-preventable learning curve. All other applications of 
cryosurgery, especially in medium and high grade malignant lesions of bone are 
confined to case reports or very small series of patients (less than 10), 
experim ental and above all, palliative with regard to tumor control.
C h a p te r 6 describes the largest series ever published of patients with simple 
bone cysts treated by curettage, cryosurgery and bone grafting. Forty-two 
patients w ere retrospectively studied of which 38%  had failed prior treatment; 
injections with steroids and or curettage with or without bone grafting. After a 
m ean clinical follow-up of 24 .5  months five patients (12% ) had a local 
recurrence. Com pared to historical controls gathered from the literature this 
recurrence rate is much better than curettage and bone grafting which has a 
recurrence rate of 29% . Injection with steroids is associated with a recurrence 
rate of 11% . These data are very much influenced by the inventer of this 
particular therapy and w ere never confirmed by others in comparable size of 
series of patients and its recurrence rate is therefore likely to be more significant.
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In 1995 Marcove, the "father of cryosurgery for bone tumors" published a series 
of 51 aneurysmal bone cysts all treated with curettage, cryosurgery and bone 
grafting and reported a recurrence rate of 17.6%. This rate was an improvement 
as compared to historical controls treated with curettage and bone grafting with a 
recurrence rate of 30.8%. In ch a p te r 7 a multicenter study of 27 aneurysmal 
bone cysts is presented all treated with curettage, cryosurgery and bone grafting. 
A recurrence rate of 4% was observed after a mean follow-up of 47 months. It is 
concluded that this kind of treatment gives comparable local tumor control as 
marginal (en block) resection, but without the need for more extensive 
reconstructive surgery with associated morbidity. The study presented is a 
conformation of Marcove's results with respect to the treatment of aneurysmal 
bone cysts by cryosurgery.
Eosinophilic granuloma is preferably treated by local injection of steroids, but 
some fail to respond or are unsuitable for this kind of therapy due to location, 
(pending) pathological fracture and/or soft tissue involvement. In ch a p te r 8 the 
use of cryosurgery for six of these type of eosinophilic granuloma of bone are 
described. After a mean follow-up of 23.3 months all lesions healed with one 
complication (pathological fracture).
In ch ap te r 9 a case report of a patient, known for bilateral retinoblastoma, with 
three chondroid lesions in the intramedullary space of one femur is presented. All 
lesions were treated with curettage, cryosurgery and bone grafting. After 33 
months of follow-up, there are no signs of recurrence. This case is the example 
of an efficient treatment with a minimal loss of bone stock, making reconstruction 
of bony defects easy as compared to segmental, marginal resections.
The clinical, radiographical and histological diagnosis and treatment of 
intramedullary chondroid lesions in the extremities is one of the controversies in 
orthopaedic oncology. In c h a p te r 10 a specific approach consisting of 
radiographic work-up (plain X-ray, bone scan, MRI or CT), biopsy and definite 
treatment is presented. The technique of cryosurgery is described in detail. 
Twenty-two patients with 26 lesions were studied and after a mean follow-up of 
25 months no recurrences were observed and all patients had excellent 
functional results.
For the local monitoring of the cryosurgical process during repetitive freeze and 
thaw cycles a computerized temperature measuring system with peroperative 
real-time graphic visualization was developed and the clinical application is 
presented in chapter 11. An in vivo study of 15 cryosurgical procedures showed 
that using a liquid nitrogen spray intralesional temperatures of -150oC were 
achieved within 10 seconds after the freeze was started.
Continuous spraying for 15 to 20 s resulted in an intralesional temperature of - 
50oC or below during a mean of 39.3 s. Spontaneous thawing between -50o and 
0oC took on the average 152.6 s. In this period the increasing temperature
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frequently entered a subzero plateaux phase varying in time from 20 to 250 s. 
Thawing from zero to 20oC required in general 290 s. In general the whole area 
around the frozen lesion cools down making the time needed for thawing to 20oC 
after every freeze longer. Reviewing the monitoring data it is concluded that this 
system is of value to ensure that the cryosurgical procedure is sufficient, but 
perhaps more important, is perfectly capable preventing unwarranted local extent 
with unnecessary morbidity. Furthermore, it is shown cryosurgery carried out with 
a spray is a reproducible method.
In c h a p te r 12 the issue of venous gas embolism during cryosurgery for bone 
tumors is investigated. Because of the experience with two patients who had 
serious cardio-pulmonary disfunction during the freezing of their bone lesions 
which were in all probability the result of venous gas embolism, a study of 15 
patients was conducted in which end tidal N2 tension was measured in an attempt 
to investigate the incidence of gas embolism during cryosurgery. Although in 
these patients no exhaled N2 was detected, it is concluded that venous gas 
embolism during cryosurgery using a spray is a significant complication and that 
the avoidance of building high pressure in the cavity is of paramount importance.
In general the following orthopaedic bone tumors are suitable for the cryosurgical 
technique described in this thesis:
* unicameral (simple) bone cyst
* aneurysmal bone cyst
* giant cell tumor
* eosinophilic granuloma
* intramedullary chondroid lesions:
- enchondroma
- chondrosarcoma grade 1
- chondroblastoma
- chondromyxoid fibroma
* fibrous dysplasia
* intramedullary hemangioma
* intramedullary schwannoma
In specific circumstances the technique can be of value for the treatment of 
malignant lesions of bone. These are:
* marginal resection of the tumor is, due to its location, not possible or induces 
unacceptable morbidity like in vertebral (chordoma) and pelvic lesions.
* marginal or wide resection is not indicated, but beneficial for local control of 
the tumor like metastasis of bone.
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Cryosurgery for bone tumors is most effectively executed with an open probe 
producing a liquid nitrogen spray. Local and general monitoring is advocated for 
a sufficient treatment and for safety of the patient. An autologous or homologous 
bone graft will eventually incorporate and will restore the normal architecture of 
the bone. During this remodeling process the extremity is weakened and partial 
weightbearing is indicated for at least 10 weeks postoperative. Diaphyseal lesions 
of the femur and tibiae should be protected against fracture with prophylactic 
internal fixation using plate and screws.
CONCLUSIONS AND ADDRESS OF THE AIMS 
OF THIS THESIS
1 This thesis defines the theoretical, technical and practical requisites for the 
effective execution of a "state of the art" cryosurgical treatment as adjuvant to 
intralesional resection of benign and low-grade malignant bone tumors.
2 This thesis contains a literature review which provides experimental evidence 
that cryosurgery is more capable to induce bone necrosis than phenol and 
cement. Furthermore, it shows that cryosurgery has been effectively used as 
adjuvant treatment for benign and low-grade malignant bone tumors.
3 This thesis describes a total of 101 of such bone tumors in 96 patients, in 6 of 
which a local recurrence occurred; a rate of 5.9%.
Five wounds (5.0%) became infected, two (2.0%) operations were 
complicated by a transient nerve palsy and 6 (6.3%) by postoperative 
pathological fracture. All patients had an excellent functional outcome.
4 This thesis reports on the development and results of a local monitoring 
system of the cryosurgical process in vivo. The system is of value to perform 
an effective freeze and to avoid an unwarranted extent of the cold injury to 
surrounding tissue.
5 This thesis describes the incidence and magnitude of venous gas embolism 
during cryosurgery for bone tumors recorded with general monitoring.
It is a continuing source for major concern and extreme caution during 
cryosurgery.
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PROBLEMS AND QUESTIONS REMAINING
Although the clinical results of cryosurgery are very promising and from the view 
of tumor control are at least equal and in the opinion of the author of this thesis 
better than other means of adjuvant treatment, there are some clinical problems 
remaining. This thesis describes several monitoring devices to prevent 
complications. Local monitoring using thermocouples has been shown to be very 
helpful in preventing unwarranted freezing of important structures adjacent to the 
lesion. But the exact extent and thus adjuvant therapy in terms of surgical margin 
is not known, other than the intralesional surface temperature. The process of 
cryosurgery, especially the duration of the freeze, is still much dependable on 
clinical judgement.
With close systemic monitoring it is possible to detect venous gas embolism 
during cryosurgery. As shown in this thesis this is a serious complication and so 
far only one death has been reported. Measuring end tidal N2 reveals venous gas 
embolism late, possibly to late, after there initiating.
Endo-oesophageal ultrasound of the heart will detect venous gas embolism a 
stage earlier, but again after the damage has already been done. Although we 
have limited experience with its use, endo-oesophageal ultrasound is at this 
moment the best technique. However, we do not know what precise echo images 
we have to look for; big "solid" or more "foamy, snowstorm" patterns?
The mechanism of N2 embolism is unclear. Gas bubbles or liquid nitrogen 
directly pushed into the venous circulation is one of the possibilities.
When during cryosurgery the surface of the cavity is getting extremely cold, the 
additional sprayed liquid nitrogen will not be able to vaporize. In stead, the bone 
marrow gets the properties comparable to a sponge and sucks the liquid nitrogen 
in small marrow spaces. This liquid nitrogen may get trapped in these marrow 
spaces. When thawing or a rise of the temperature is allowed, the trapped liquid 
nitrogen will boil and vaporize building extremely high pressures.
It may be possible that under these circumstances liquid nitrogen or gaseous 
nitrogen is pushed into the venous circulation*.
It may be possible that we have to look for venous gas embolism in more 
centrally located veins like in the abdomen or thorax.
Postoperative fracture of the remodelling bone subjected to cryosurgery, is not 
only very distressing for the patient, but also compromises the orthopaedic 
oncologic status; first there was an intra-compartimental disease, due to the 
fracture it has now potentially changed to an extra-compartimental disease.
In our experience fracture is most likely to occur one to four weeks after the 
cryosurgical treatment. We do not know the biological course concerning strength 
of bone after cryosurgery.
* personal communication with J. van Egmond
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The bony defects resulting after curettage of bone tumors are generally filled with 
a bone graft. For tumor control it is probably useless as has been shown in the 
results of the treatment of unicameral and aneurysmal bone cysts. Furthermore it 
is a potential cause of transmitting diseases and infection.
Is the use of a bone graft to reconstruct the bony defect helpful in healing this 
defect? Does it strengthen the bone, does it accelerate the restoration of the 
bony architecture? If so, what source is best, allograft or autograft?
Research investigating these questions is currently directed in this way in an 
effort to answer these questions.
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SAMENVATTING EN AFSLUITENDE OPMERKINGEN
Actieve en agressieve goedaardige en laaggradig kwaadaardige bottumoren 
worden in het algemeen behandeld met intralesionale resectie. Aanvullende 
therapie met het doel de chirurgische marge te vergroten wordt gegeven om 
achtergebleven tumor cellen te vernietigen, welke anders verantwoordelijk 
kunnen zijn voor een recidief van de tumor.
Dit proefschrift beschrijft het gebruik van een specifiek type aanvullende 
behandeling: cryochirurgie. Het is de destructie van weefsel in situ door de lokale 
inwerking van zeer lage temperaturen.
Het onderstaande is een een samenvatting van het proefschrift. Voor een 
uitgebreide discussie van de verschillende onderwerpen wordt de lezer dezes 
verwezen naar de specifieke hoofdstukken, hoewel aan het einde van deze 
paragraaf enkele afsluitende opmerkingen worden gemaakt.
In h o o fd s tu k  1 worden de doelstellingen van het proefschrift geformuleerd; de 
beschrijving van effectieve cryochirurgie, een overzicht van de literatuur, een 
evaluatie van de klinische resultaten van cryochirurgie van bottumoren en de 
ontwikkeling van instrumenten en resultaten voor lokale en systemische 
bewaking alsmede monitoring tijdens cryochirurgie.
In h o o fd s tu k  2 wordt het duidelijk dat het therapeutisch gebruik van lage 
temperaturen een lange historische achtergrond heeft en haar toepassing heeft 
gevonden in bijna elk medisch specialisme. De verdovende eigenschappen van 
lage temperaturen werden het eerst onderkend. Later werden de voordelen als 
verzachtende behandeling van kwaadaardige tumoren erg gewaardeerd. In die 
tijd werd de potentiële kracht voor weefseldestructie door lage temperaturen 
herkend.
De ontwikkeling van geschikte apparaten voor het induceren van een koude 
letsel in een specifiek doelgebied, nu bekend onder de naam cryochirurgie of 
cryotherapie, gaf de medici een krachtig wapen in handen voor de bestrijding van 
goedaardige en kwaadaardige tumoren.
Als men, in tijden van moderne geneeskunst gebruik wil maken van cryochirurgie 
in het algemeen en voor bottumoren in het bijzonder, is het noodzakelijk om alle 
basale factoren en principes te onderzoeken en te formuleren, zodat een "state 
of the art" cryochirurgische behandeling kan worden uitgevoerd.
De basale principes, die ten grondslag liggen aan een effectieve cryochirurgie 
van bottumoren, worden geformuleerd in hoofdstuk 3. Verschillende typen 
cryoprobes worden vergeleken en geconcludeerd wordt dat een open cryoprobe, 
die een spray van vloeibare stikstof produceert, een extreme hoge koeling 
capaciteit heeft (-175^). Deze is het meest geschikt voor het bevriezen van 
irregulaire oppervlakten van benige holten, zoals die achterblijven na de 
curettage van bottumoren. Daarnaast is het met open cryoprobes mogelijk om 
zeer hoge bevriezingssnelheden te bereiken.
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H et monitoren van het cryochirurgische proces is van belang om een effectieve 
behandeling te garanderen en om een ongewilde uitbreiding van het vriesletsel te 
voorkom en, welke een potentiële bron voor morbiditeit zou kunnen zijn. 
Verschillende monitorings mogelijkheden worden beschreven en geconcludeerd  
wordt dat het lokale gebruik van temperatuursensoren, gemonteerd in het 
uiteinde van een holle naald de m eest praktische oplossing is voor het monitoren 
en bewaken van cryochirurgie voor de behandeling van bottumoren.
Cryobiologie; de studie van fysieke effecten van lage tem peraturen op levend 
w eefsel wordt beschreven in h o o fd s tu k  4. Cryobiologie verklaart de 
destruerende eigenschappen van een koude letsel aan een individuele cel. Het 
geeft ook aan hoe de m eest effectieve wijze van cryochirurgie dient te worden  
uitgevoerd; zee r snelle bevriezing, die gepaard gaat met een dodelijke 
intracellulaire ijsvorming door mechanische beschadiging van de celm em branen, 
een minimum tem peratuur van -50oC en langzam e ontdooiing. Dit laatste gaat 
opnieuw gepaard met intracellulaire rekristallisatie van w ater en dus opnieuw met 
m em braan beschadiging. Verder is het herhalen van vries en dooi cycli vereist 
en een praktische oplossing voor de behandeling van insufficiënt bevroren 
gebieden tijdens eerdere cycli en voor het compenseren van de capaciteit van 
levend weefsel om een thermische beschadiging te weerstaan.
Een literatuur overzicht, met de intentie compleet te zijn, wordt gepresenteerd in 
h o o fd s tu k  5. Door gebruik te maken van M E D LIN E  E X P R E S S  1965 - 1996  
worden alle experim entele en klinische data betreffende cryochirurgie in relatie 
tot het skelet sam engevat. Uit deze gegevens wordt het duidelijk dat bevroren 
bot binnen een w eek avitaal is. Osteogenesis voortkomend uit normaal bot en 
botvlies vlak naast het bevroren bot begint binnen enige dagen. Revitalisatie van 
dood bot door gelijktijdige resorptie en verbening duurt enige maanden. 
Experim enten betreffende de effectiviteit van aanvullende behandeling voor het 
verkrijgen van perifere additionele necrose na curettage, laten zien dat 
cryochirurgie superieur is aan het gebruik van fenol en cement.
H et klinisch gebruik van cryochirurgie beschreven in series van 25 of m eer 
patiënten met specifieke bottumoren is schaars en uitgevoerd in minder dan vijf 
verschillende instituten in de wereld. W at betreft de controle van de tumoren zijn 
de resultaten goed tot uitstekend. Aanvankelijk werden hoge aantallen  
complicaties gerapporteerd, m aar deze dalen, conform de niet te vermijden 
leercurve tot een acceptabel niveau.
Toepassingen van cryochirurgie voor de behandeling van middel en hooggradige 
tumoren van bot zijn niet alleen beperkt gebleven tot publikaties van aparte 
ziektegeschiedenissen (m inder dan 10), m aar ook experim enteel en wellicht 
palliatief in de zin van tumorcontrole.
H o o fd s tu k  6 beschrijft de grootste serie ooit gepubliceerd betreffende patiënten 
met simpele botcysten behandeld met curettage, cryochirurgie en botgrafting. 
R etrospectief werden 42 patiënten bestudeerd; 38%  had een eerdere gefaalde
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behandeling ondergaan met injectie van steroiden en/of curettage met of zonder 
botgrafting. Na een gemiddelde follow-up van 24,5 maanden hadden vijf 
patiënten (12%) een lokaal recidief. Vergeleken met het percentage van 29% bij 
controle patiënten behandeld met curettage en botgrafting verzameld in de 
literatuur is dit beter. Injectie therapie met steroiden heeft een recidief 
percentage van 11%. Dit percentage wordt erg beïnvloed door de uitvinder van 
deze therapie en werd nooit herhaald door anderen in vergelijkbare series van 
patiënten. Het recidief percentage is daarom waarschijnlijk hoger.
In 1995 publiceerde Marcove, die het gebruik van cryochirurgie voor bottumoren 
introduceerde, een serie van 51 patiënten met een aneurysmatische botcyste, 
allen behandeld met curettage, cryochirurgie en botgrafting en rapporteerde een 
recidief percentage van 17,6%. Dit percentage is een verbetering vergeleken met 
een historische controle groep van patiënten behandeld met curettage en 
botgrafting, die een recidief percentage van 30,8% kent. In h o o fd s tu k  7 wordt 
een studie beschreven van 27 aneurysmatische bot cysten, alle behandeld in de 
academische ziekenhuizen van Nijmegen en Groningen met curettage, 
cryochirurgie en botgrafting. Na een gemiddelde follow-up van 47 maanden werd 
een recidief percentage van 4% geconstateerd. Geconcludeerd wordt dat deze 
behandeling vergelijkbare lokale controle van de tumor geeft als marginale 
resectie, maar zonder de noodzaak voor een soms ingewikkelde benige 
reconstructie, wat met een hogere kans op additionele morbiditeit gepaard gaat. 
De gepresenteerde studie is de eerste die de resultaten van Marcove voor dit 
type tumor bevestigd.
Eosinofiele granulomen van bot worden bij voorkeur behandeld met de 
intralesionale injectie van corticosteroiden. Helaas reageren sommige eosinofiele 
granulomen van bot niet op deze behandeling of zijn ongeschikt om op dergelijke 
wijze te behandelen. Dit kan komen door een ongunstige lokatie, een dreigende 
pathologische fractuur en/of weke delen uitbreiding. In h o o fd s tu k  8 worden 6 
van dergelijke eosinofiele granulomen van bot besproken, alle behandeld met 
cryochirurgie. Na een gemiddelde follow-up van 23,3 maanden zijn alle lesies 
genezen. Er was één complicatie in de zin van een pathologische fractuur, welke 
na osteosynthese restloos is genezen.
In h o o fd s tu k  9 wordt een patiënt beschreven die in één femur twee 
enchondromen en een chondrosarcoom graad 1 ontwikkelde 25 jaar nadat zij 
behandeld werd voor een retinoblastoom van beide ogen. De drie chondroide 
tumoren werden behandeld met curettage, cryochirurgie en botgrafting. Na een 
follow-up van 33 maanden zijn er geen tekenen van een recidief. Deze 
ziektegeschiedenis is hèt voorbeeld van de botsparende eigenschappen van 
deze behandeling, zonder toe te geven aan de effectiviteit in de zin van controle 
van de tumor.
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Over de klinische, radiologische en histologische diagnose en behandeling van 
intramedullaire kraakbenige tumoren in de ledematen, bestaat enige onenigheid 
binnen de groep van specialisten die zich bezig houdt met orthopaedische 
oncologie. In h o o fd s tu k  10 wordt een specifieke benadering bestaande uit 
radiologisch onderzoek (röntgenfoto's, CT of MRI), biopsie en definitieve 
behandeling middels curettage en cryochirurgie gepresenteerd. De techniek van 
cryochirurgie wordt tot in detail besproken.
22 Patiënten met 26 lesies werden aldus behandeld en na een gemiddelde 
follow-up van 25 maanden werden geen lokale recidieven waargenomen en alle 
patiënten hadden een excellent functioneel resultaat.
De ontwikkeling van een temperatuur meetsysteem voor de lokale monitoring 
van vries/dooi cycli wordt in h o o fd s tu k  11 gepresenteerd. Het systeem maakt 
gebruik van temperatuursensoren, waarvan de gemeten temperaturen grafisch 
op een computer monitor (real-time) kunnen worden afgelezen. Een in vivo 
studie van 15 cryochirurgische procedures liet zien, dat bij gebruik van een 
vloeibare stikstof spray, intralesionale temperaturen van -150oC kunnen worden 
bereikt. Wordt het sprayen gedurende 15 tot 20 seconden voortgezet dan blijft de 
intralesionale oppervlakte temperatuur gedurende 40 seconden onder -50oC. 
Spontane ontdooiing tussen de -50oC en 0oC nam ongeveer 152 seconden in 
beslag. In deze periode werd vaak een net onder de 0oC gelegen plateau fase 
gezien, waarin de temperatuur niet lineair met tijd steeg. Verder opwarmen van 
het bevroren weefsel van 0 tot 20oC duurde gemiddeld ongeveer 290 sec.
In het algemeen koelde het gehele gebied af wat de opwarmtijd van de tweede 
en derde cyclus steeds langer maakte.
Op grond van deze data kan men concluderen dat dit meetsysteem bijdraagt aan 
het verhogen van de effectiviteit van cryochirurgie en waardevol is bij het 
voorkomen van een te groot koude letsel resulterend in onnodige morbiditeit.
Ook werd duidelijk dat het gebruik van een spray een goed reproduceerbare 
methode voor het uitvoeren van cryochirurgie is.
In h o o fd s tu k  12 wordt het fenomeen en een studie van veneuze gas embolieën 
tijdens cryochirurgie besproken. Dit naar aanleiding van twee patiënten bij wie, 
tijdens een cryochirurgische behandeling, ernstige cardio-pulmonaire 
complicaties optraden, waarschijnlijk als gevolg van dergelijk embolieën.
Bij 15 patiënten werd tijdens cryochirurgie de stikstofspanning in de 
uitademingslucht gemeten met behulp van een massaspectrograaf in een poging 
een idee van de incidentie van veneuze stikstofembolieën te verkrijgen. Ondanks 
dat bij geen enkele patiënt N2 in de uitademingslucht werd geconstateerd, kan 
cryochirurgie gepaard gaan met cardio-pulmonaire instabiliteit, die waarschijnlijk 
het gevolg is van veneuze stikstof embolieën. Derhalve dient tijdens 
cryochirurgie met een spray het opbouwen van druk in de intramedullaire ruimte 
te worden voorkomen.
126 Hoofdstuk 13
In het algemeen zijn de volgende botumoren geschikt voor de cryochirurgische 
techniek zoals beschreven in dit proefschrift:
* unicamerale (simpele) botcyste
* aneurysmatische botcyste
* reusceltumor
* eosinofiel granuloom
* intramedullaire chondroïde lesies:
- enchondroma
- chondrosarcoma graad 1
- chondroblastoom
- chondromyxoid fibroom
* fibreuze dysplasie
* intramedullair haemangioom
* intramedullair schwannoom
In geval van specifieke omstandigheden kan deze techniek ook van waarde zijn 
bij de behandeling van kwaadaardige bottumoren. Deze zijn:
* marginale resectie van de tumor is niet mogelijk of zou resulteren in 
onaanvaardbare morbiditeit. Deze situatie doet zich met name voor bij 
tumoren gelocaliseerd in de wervelkolom (chordoom) en bekken.
* marginale of ruime resectie is niet geïndiceerd, maar locale controle is 
gewenst. Deze situatie doet zich soms voor bij de behandeling van ossale 
metastasen.
Cryochirurgie van bottumoren wordt het meest efficient uitgevoerd met een open 
probe, die een vloeibare stikstof spray produceert. Locaal en algemeen 
monitoren en bewaken is noodzakelijk voor een sufficiënte behandeling en 
veiligheid van de patiënt.
Een autologe of homolge botgraft zal uiteindelijk incorporeren en de normale 
architectuur van het bot herstellen. Gedurende dit remodellerings proces is het 
bot minder sterk en is in geval van de onderste extremiteit voor minstens 10 
weken slechts partieel belastbaar. Diafysaire femorale en tibiale lesies dienen 
profylactisch met interne fixatie te worden verstevigd.
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CONCLUSIES EN BESCHOUWING VAN DE DOELSTELLINGEN 
VAN DIT PROEFSCHRIFT
1 Dit proefschrift definieert de theoretische, technische en praktische 
voorwaarden voor de uitvoering van een "state of the art" cryochirurgische 
behandeling als aanvulling op intralesionale resectie van goedaardige en 
laaggradig kwaadaardige bottumoren.
2 Dit proefschrift bevat een overzicht van de literatuur, waaruit blijkt dat er 
sterke aanwijzingen zijn dat cryochirurgie beter in staat is tot het veroorzaken 
van necrose van bot dan phenol and cement.
Uit het overzicht blijkt verder dat cryochirurgie met succes als adjuvans is 
gebruikt voor de behandeling van goedaardige en laaggradig maligne 
bottumoren.
3 Dit proefschrift beschrijft 101 van dergelijk bottumoren bij 96 patiënten, alle 
behandeld met curettage en cryochirurgie. Zes lesies (5,9%) recidiveerden 
lokaal. Bij vijf patiënten (5.0%) raakte de wond postoperatief geïnfecteerd, 
twee (2,0%) operaties werden gecompliceerd door een voorbijgaande uitval 
van een zenuw. Hoewel er zes (5,9%) pathologische fracturen optraden, 
hadden alle patiënten uiteindelijk een excellent functioneel resultaat.
4 Dit proefschrift beschrijft de ontwikkeling van een lokaal monitoring en 
bewakings systeem van cryochirurgie in vivo. Het systeem draagt bij aan een 
effectieve cryochirurgische behandeling en aan het voorkomen van een 
onbedoelde uitbreiding van het koude letsel in het omgevende weefsel.
5 Dit proefschrift beschrijft de incidentie en ernst van veneuze gasembolieën in 
patiënten. Het is een blijvende zorg en vereist een continue alertheid.
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Hoewel de klinische resultaten van cryochirurgie veelbelovend zijn en wat betreft 
de lokale controle van de tumor op zijn minst gelijk zijn, en naar de mening van 
de schrijver van dit proefschrift zelfs beter dan andere vormen van adjuvante 
behandeling, resteren er een aantal klinische problemen. Dit proefschrift 
beschrijft een aantal bewakings en monitor mogelijkheden voor het vermijden 
van complicaties. Lokale monitoring met behulp van temperatuurmetingen is 
zeer geschikt voor de preventie van een te uitgebreide vrieslesie, die anders 
omgevende belangrijke structuren zou beschadigen. De precieze uitbreiding van 
dit vriesletsel blijft echter onduidelijk en dus ook de mate van de aanvullende 
weefsel necrose. Het gehele cryochirurgische proces, met name de duur van het 
vriezen blijft voor een belangrijk deel afhankelijk van de klinische blik.
Met algemene anaesthesiologische bewaking van een patiënt is het mogelijk 
veneuze gasembolieën te signaleren, hetgeen een levensbedreigende 
complicatie kan zijn. Het meten van N2 in de uitademingsgassen detecteert 
gasembolieën laat, mogelijk te laat, na het ontstaan van veneuze gasembolieën. 
Met endo-oesophageale echografie van het hart kunnen gasembolieën een 
stadium eerder worden waargenomen, maar nog steeds nadat het kwaad al is 
opgetreden. Hoewel we slechts minimale ervaring hebben met deze techniek, 
lijkt deze momenteel het beste. Helaas weten we niet precies wat voor 
echobeelden afwijkend zijn en hoe deze er uitzien; zijn het grote solide emboliën 
of meer kleine "schuimachtige, sneeuwstorm" patronen?
Het mechanisme van ontstaan van gasembolieën is ook onduidelijk. Worden 
gasbelletjes of vloeibare stikstof direct in de veneuze circulatie geperst?
Als de oppervlakte van een benige holte tijdens cryochirurgie extreem koud 
wordt dan krijgt deze de fysische eigenschappen van een spons. Vloeibare 
stikstof wordt in het beenmerg gezogen en het is voorstelbaar dat het daar in de 
kleine trabeculaire structuren "gevangen" raakt. Bij opwarmen zal opgesloten 
vloeibare stikstof verdampen wat gepaard gaat met de opbouw van zeer hoge 
drukken. Het is mogelijk dat onder deze omstandigheden stikstofgas of vloeibare 
stikstof in de circulatie wordt geperst*.
Het is misschien noodzakelijk om in meer centraal gelegen veneuze vaten te 
kijken zoals bijvoorbeeld in het abdomen.
Postoperatieve fracturen zijn niet allen voor de patiënt erg vervelend, maar 
compromitteren ook de oncologische situatie; was er eerst sprake van een intra- 
compartimentele ziekte, dan is deze door de fractuur veranderd in een potentiële 
extra-compartimentele ziekte.
Onze ervaring is dat pathologische fracturen het vaakst enkele weken na de 
cryochirurgische behandeling optreden. Helaas ontbreekt ons het inzicht in het 
biologische verloop van de sterkte van bot na cryochirurgie en hoe dit
*  Persoonlijke communicatie met J. van Egmond
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gerelateerd is aan het remodellerings proces.
De botdefecten die overblijven na curettage en cryochirurgie worden doorgaans 
gevuld met een botgraft. Voor de additionele waarde in de zin van tumorcontrole 
heeft het geen zin, zoals gedemonstreerd in de resultaten van de behandeling 
van unicamerale en aneurysmatische botcysten. Botdonaties blijven, ondanks de 
zorgvuldige testen, een bron van overdraagbare ziekten en infectie.
Is het gebruik van een botgraft dan nuttig voor het helen van het defect? Helpt 
het het bot te versterken en wordt het herstel van de botstructuur versneld? Zo 
ja, wat is beter; een allograft of autograft?
Onze huidige onderzoeken worden momenteel in deze richting geredigeerd.
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